<?xml version='1.0' encoding='UTF-8' standalone='no'?>
<sbml xmlns="http://www.sbml.org/sbml/level3/version1/core" layout:required="false" level="3" qual:required="true" version="1" xmlns:layout="http://www.sbml.org/sbml/level3/version1/layout/version1" xmlns:qual="http://www.sbml.org/sbml/level3/version1/qual/version1">
  <model id="M49567" metaid="d6d3b451-66f4-4f9a-a549-c2ed51cb80ce" name="Virtual chondrocyte - GRN layer">
    <notes>
      <body xmlns="http://www.w3.org/1999/xhtml">Comprehensive regulatory network of chondrocyte differentiation. The focus is on articular cartilage and osteoarthritis: growth plate network was used as a starting point and  was extended to articular cartilage chondrocyte. The full regulatory network is composed of 2 layers: (1) the protein signalling pathways (from growth factors to the transcription factors) and (2) the gene regulatory network (transcription factors regulating the gene that code for the upstream proteins). This version corresponds to the part (2) gene regulatory network.</body>
	  <div class="dc:title">Lesage 2022 - The virtual chondrocyte: articular chondrocyte regulatory network - GRN layer </div>
	  <div class="dc:bibliographicCitation">
	  <p>This model is described in the article:</p>
	  <div class="bibo:title">
		<a href="https://doi.org/10.1101/2021.09.27.461207" title="Access to this publication">An integrated in silico-in vitro approach for identification of therapeutic drug targets for osteoarthritis - preprint </a>
	  </div>
	  <div class="bibo:authorList">Raphaëlle Lesage, Mauricio N. Ferrao Blanco,
	  Roberto Narcisi, Tim Welting, Gerjo J.V.M. van Osch, Liesbet Geris</div>
	  <div class="bibo:Journal">bioRxiv 2021.09.27.461207</div>
	  <p>Abstract:</p>
	  <div class="bibo:abstract">
		<p>BACKGROUND:Without the availability of disease-modifying drugs, there is an unmet therapeutic
		need for osteoarthritic patients. During osteoarthritis, the homeostasis of articular chondrocytes
		is dysregulated and a phenotypical transition called hypertrophy occurs, leading to cartilage
		degeneration. Targeting this phenotypic transition has emerged as a potential therapeutic strategy.
		Chondrocyte phenotype maintenance and switch are controlled by an intricate network of intracellular
		factors, each influenced by a myriad of feedback mechanisms, making it challenging to intuitively
		predict treatments outcomes, while in silico modeling can help unravel that complexity. In this study,
		we aim to develop a virtual articular chondrocyte to guide experiments in order to rationalize the
		identification of potential drug targets via screening of combination therapies through computational
		modeling and simulations. RESULTS: We developed a signal transduction network model using knowledge-based
		and data-driven (machine learning) modelling technologies. The in silico high-throughput screening of
		(pairwise) perturbations operated with that network model highlighted conditions potentially affecting
		the hypertrophic switch. A selection of promising combinations were further tested in a murine cell line
		and primary human chondrocytes, which notably highlighted a previously unreported synergistic effect 
		between the Protein Kinase A and the Fibroblast Growth Factor Receptor 1. CONCLUSION: Here, we provide
		a virtual articular chondrocyte in the form of a signal transduction interactive knowledge base and of
		an executable computational model. Our in silico-in vitro strategy opens new routes for developing
		osteoarthritis targeting therapies by refining the early stages of drug targets discovery.
	 </p>
	 </div>
	</div>	  
    </notes>
    <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:vCard="http://www.w3.org/2001/vcard-rdf/3.0#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#d6d3b451-66f4-4f9a-a549-c2ed51cb80ce">
	<dc:creator>
	<rdf:Bag>
	<rdf:li rdf:parseType="Resource">
	<vCard:N rdf:parseType="Resource">
	<vCard:Family>Lesage</vCard:Family>
	<vCard:Given>Raphaelle</vCard:Given>
	</vCard:N>
	<vCard:EMAIL>raphaelle.lesage@kuleuven.be</vCard:EMAIL>
	<vCard:ORG rdf:parseType="Resource">
	<vCard:Orgname>KU Leuven</vCard:Orgname>
	</vCard:ORG>
	</rdf:li>
	</rdf:Bag>
	</dc:creator>
	<dcterms:created rdf:parseType="Resource">
	<dcterms:W3CDTF>2019-02-05T04:22:17Z</dcterms:W3CDTF>
	</dcterms:created>
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2022-08-01T08:49:22Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
      <layout:listOfLayouts xmlns:layout="http://www.sbml.org/sbml/level3/version1/layout/version1" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
      <layout:layout layout:name="New Layout 2">
        <layout:listOfAdditionalGraphicalObjects>
          <layout:generalGlyph layout:id="S_15_glyph" layout:reference="S_15">
            <layout:boundingBox>
              <layout:position layout:x="-37.7952441059562" layout:y="-13.867361518753505" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_40_glyph" layout:reference="S_40">
            <layout:boundingBox>
              <layout:position layout:x="35.011870970285656" layout:y="12.88132253321784" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_1_glyph" layout:reference="S_1">
            <layout:boundingBox>
              <layout:position layout:x="9.591856817551864" layout:y="42.06625128692042" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_48_glyph" layout:reference="S_48">
            <layout:boundingBox>
              <layout:position layout:x="-27.671191891290462" layout:y="13.261635576610793" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_56_glyph" layout:reference="S_56">
            <layout:boundingBox>
              <layout:position layout:x="-1.667517621968038" layout:y="11.661632488757498" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_52_glyph" layout:reference="S_52">
            <layout:boundingBox>
              <layout:position layout:x="1.43383792565497" layout:y="-5.430009344543933" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_24_glyph" layout:reference="S_24">
            <layout:boundingBox>
              <layout:position layout:x="-9.095990417197292" layout:y="6.796313838930516" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_17_glyph" layout:reference="S_17">
            <layout:boundingBox>
              <layout:position layout:x="41.73438470204336" layout:y="-16.783094851432836" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_4_glyph" layout:reference="S_4">
            <layout:boundingBox>
              <layout:position layout:x="-33.22931281541629" layout:y="41.65834281661827" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_30_glyph" layout:reference="S_30">
            <layout:boundingBox>
              <layout:position layout:x="-18.600641040401527" layout:y="39.50323557072485" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_47_glyph" layout:reference="S_47">
            <layout:boundingBox>
              <layout:position layout:x="39.92871510530459" layout:y="41.02448774429668" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_51_glyph" layout:reference="S_51">
            <layout:boundingBox>
              <layout:position layout:x="-0.21301386164326175" layout:y="23.15302154102457" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_54_glyph" layout:reference="S_54">
            <layout:boundingBox>
              <layout:position layout:x="16.30152739550398" layout:y="37.981983397153016" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_44_glyph" layout:reference="S_44">
            <layout:boundingBox>
              <layout:position layout:x="-43.854586225046674" layout:y="-42.70649662848814" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_53_glyph" layout:reference="S_53">
            <layout:boundingBox>
              <layout:position layout:x="37.75395712250776" layout:y="23.910400791613597" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_22_glyph" layout:reference="S_22">
            <layout:boundingBox>
              <layout:position layout:x="8.62106015548089" layout:y="4.053761271865881" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_13_glyph" layout:reference="S_13">
            <layout:boundingBox>
              <layout:position layout:x="35.99467322729836" layout:y="-41.4762996257505" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_26_glyph" layout:reference="S_26">
            <layout:boundingBox>
              <layout:position layout:x="48.626840468800076" layout:y="-35.42100920125212" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_39_glyph" layout:reference="S_39">
            <layout:boundingBox>
              <layout:position layout:x="27.44749537794884" layout:y="41.65834281661827" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_60_glyph" layout:reference="S_60">
            <layout:boundingBox>
              <layout:position layout:x="11.12462798929154" layout:y="32.24163504841732" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_37_glyph" layout:reference="S_37">
            <layout:boundingBox>
              <layout:position layout:x="37.94306651231618" layout:y="34.81270803554504" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_34_glyph" layout:reference="S_34">
            <layout:boundingBox>
              <layout:position layout:x="-40.610488433778464" layout:y="22.135606589113134" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_35_glyph" layout:reference="S_35">
            <layout:boundingBox>
              <layout:position layout:x="-45.1420548109076" layout:y="35.3034516676806" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_19_glyph" layout:reference="S_19">
            <layout:boundingBox>
              <layout:position layout:x="-46.720965644544236" layout:y="6.819861034985422" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_57_glyph" layout:reference="S_57">
            <layout:boundingBox>
              <layout:position layout:x="-38.02436159025458" layout:y="5.107513562578092" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_9_glyph" layout:reference="S_9">
            <layout:boundingBox>
              <layout:position layout:x="-47.11626582883013" layout:y="-3.5859428357975816" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_14_glyph" layout:reference="S_14">
            <layout:boundingBox>
              <layout:position layout:x="11.915228357863327" layout:y="-2.927347654102455" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_42_glyph" layout:reference="S_42">
            <layout:boundingBox>
              <layout:position layout:x="-33.09262437803922" layout:y="-0.5564049999999909" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_33_glyph" layout:reference="S_33">
            <layout:boundingBox>
              <layout:position layout:x="-22.8703205732733" layout:y="-6.6479163645973" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_45_glyph" layout:reference="S_45">
            <layout:boundingBox>
              <layout:position layout:x="-25.1540886697391" layout:y="-18.364568520122" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_2_glyph" layout:reference="S_2">
            <layout:boundingBox>
              <layout:position layout:x="-15.096950901672741" layout:y="-29.271154921907538" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_25_glyph" layout:reference="S_25">
            <layout:boundingBox>
              <layout:position layout:x="-2.02283511248676" layout:y="-26.544462965185417" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_11_glyph" layout:reference="S_11">
            <layout:boundingBox>
              <layout:position layout:x="12.001136894152012" layout:y="10.376275016139118" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_46_glyph" layout:reference="S_46">
            <layout:boundingBox>
              <layout:position layout:x="2.1889956014404817" layout:y="-43.85341134398571" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_58_glyph" layout:reference="S_58">
            <layout:boundingBox>
              <layout:position layout:x="34.822761580477234" layout:y="41.02448774429668" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_7_glyph" layout:reference="S_7">
            <layout:boundingBox>
              <layout:position layout:x="-39.96171503441" layout:y="-22.4510368199161" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_18_glyph" layout:reference="S_18">
            <layout:boundingBox>
              <layout:position layout:x="21.6224458754363" layout:y="13.0368002647177" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_20_glyph" layout:reference="S_20">
            <layout:boundingBox>
              <layout:position layout:x="32.17523012315935" layout:y="34.43239499215209" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_10_glyph" layout:reference="S_10">
            <layout:boundingBox>
              <layout:position layout:x="10.6281299171567" layout:y="21.3494167896177" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_43_glyph" layout:reference="S_43">
            <layout:boundingBox>
              <layout:position layout:x="22.980148809473633" layout:y="21.44067406861724" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_6_glyph" layout:reference="S_6">
            <layout:boundingBox>
              <layout:position layout:x="28.7616120821114" layout:y="7.72596192936489" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_5_glyph" layout:reference="S_5">
            <layout:boundingBox>
              <layout:position layout:x="-13.120449980243272" layout:y="-4.244538017492708" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_12_glyph" layout:reference="S_12">
            <layout:boundingBox>
              <layout:position layout:x="35.552843966668135" layout:y="4.378522604798377" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_50_glyph" layout:reference="S_50">
            <layout:boundingBox>
              <layout:position layout:x="-19.44705688749348" layout:y="29.74186745697227" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_16_glyph" layout:reference="S_16">
            <layout:boundingBox>
              <layout:position layout:x="-13.0739018890046" layout:y="19.2712626583927" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_59_glyph" layout:reference="S_59">
            <layout:boundingBox>
              <layout:position layout:x="-35.22765306035404" layout:y="13.515177605539435" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_31_glyph" layout:reference="S_31">
            <layout:boundingBox>
              <layout:position layout:x="40.40933022504669" layout:y="-4.903133199187835" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_23_glyph" layout:reference="S_23">
            <layout:boundingBox>
              <layout:position layout:x="-15.291226718754174" layout:y="11.36007035964601" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_3_glyph" layout:reference="S_3">
            <layout:boundingBox>
              <layout:position layout:x="-19.18971208571024" layout:y="20.6503598505831" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_32_glyph" layout:reference="S_32">
            <layout:boundingBox>
              <layout:position layout:x="-8.679432263363104" layout:y="15.249879360683046" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_21_glyph" layout:reference="S_21">
            <layout:boundingBox>
              <layout:position layout:x="18.985670262627195" layout:y="-38.33416731036709" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_28_glyph" layout:reference="S_28">
            <layout:boundingBox>
              <layout:position layout:x="-25.638289149296575" layout:y="3.395166090170761" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_41_glyph" layout:reference="S_41">
            <layout:boundingBox>
              <layout:position layout:x="19.253220944793384" layout:y="-15.045498997292796" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_49_glyph" layout:reference="S_49">
            <layout:boundingBox>
              <layout:position layout:x="-30.81700957560226" layout:y="-25.056145759058737" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_29_glyph" layout:reference="S_29">
            <layout:boundingBox>
              <layout:position layout:x="-5.551104639698593" layout:y="40.01031962858213" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_38_glyph" layout:reference="S_38">
            <layout:boundingBox>
              <layout:position layout:x="14.760985345655342" layout:y="-46.3207412216192" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_36_glyph" layout:reference="S_36">
            <layout:boundingBox>
              <layout:position layout:x="21.058821724292358" layout:y="-27.95396455851727" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_8_glyph" layout:reference="S_8">
            <layout:boundingBox>
              <layout:position layout:x="-16.908931393827757" layout:y="-13.126503615995844" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_55_glyph" layout:reference="S_55">
            <layout:boundingBox>
              <layout:position layout:x="26.411090033011632" layout:y="1.5510995814244097" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
          <layout:generalGlyph layout:id="S_27_glyph" layout:reference="S_27">
            <layout:boundingBox>
              <layout:position layout:x="-8.535836541064334" layout:y="-45.982064546634476" layout:z="0"/>
            </layout:boundingBox>
          </layout:generalGlyph>
        </layout:listOfAdditionalGraphicalObjects>
      </layout:layout>
    </layout:listOfLayouts>
    <qual:listOfQualitativeSpecies xmlns:qual="http://www.sbml.org/sbml/level3/version1/qual/version1">
      <qual:qualitativeSpecies metaid="_98b214fc-b9e4-46c2-88a9-c506cccba716" qual:compartment="cytosol" qual:constant="false" qual:id="S_1" qual:initialLevel="0" qual:maxLevel="1" qual:name="FOXO">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>Deletion of Foxo showed that it is involved in expression of Col2a1 and Acan in cartilage</p><p>FOXO synergize with the TGF-beta pathway to regulate downstream targets</p><p>Regulation of transcription</p><p>Forkhead Box O. E.g. Foxo1 MGI:1890077, NCBI Gene: 56458</p><p>FOXO expression is dyregulated (reduced) during ageing and osteoarthritis.</p><p>FOXO is involved in the regulation of several ECM component and the deletion of Foxo resulted in spontenous degradation of articular cartilage.</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#_98b214fc-b9e4-46c2-88a9-c506cccba716">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2021-02-08T14:15:57Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="_73f6b235-22eb-4942-950d-854a57bfb1f3" qual:compartment="cytosol" qual:constant="false" qual:id="S_2" qual:initialLevel="0" qual:maxLevel="1" qual:name="Dlx5">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>homeobox transcription factor similar to Drosophila distal-less, important role in bone development and healing. NB: Homeobox proteins are transcription factors that direct proper development by regulating specific temporal and spatial patterns of gene expression.</p><p>Dlx5 is expressed in (pre)hypertrophic chondrocyte and has a transcription activity promoting hypertrophy. Notably it would directly bind and activate Runx2 promotor.</p><p>distal-less homeobox 5: MGI:101926, NCBI gene:13395</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#_73f6b235-22eb-4942-950d-854a57bfb1f3">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2019-02-05T04:22:17Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="d7fc5c36-201f-432f-82e7-41fa91f271d4" qual:compartment="cytosol" qual:constant="true" qual:id="S_3" qual:initialLevel="0" qual:maxLevel="1" qual:name="Ras">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>Ras is a proto-oncogne, part of the GTPases familly. Ras proteins are activated after activation of a transmembranar receptor (mainly EGFR Epidermal Growth Factor receptor for the canonical pathway). Activation of Ras by phosphorylation leads to downstream cascade of Kinase activation (MEK/ERK), which contributes to transduce the signal up to the nucleus.</p><p>GTPases of the Ras superfamily.</p><p>the Ras protein and Ras/ERK1/2 axis are  involved in many non-canonical biochemical signals</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#d7fc5c36-201f-432f-82e7-41fa91f271d4">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2019-02-05T04:22:17Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="e3896f81-1bbc-468d-bcca-ecf2d0cc85de" qual:compartment="cytosol" qual:constant="false" qual:id="S_4" qual:initialLevel="0" qual:maxLevel="1" qual:name="Sox9">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>SRY (sex determining region Y)-box 9 (Sox9) MGI:98371, NCBI gene: 20682</p><p>DNA-binding protein. It is one of the major transcription factor involved during chondrocyte differentiation.  Deficiencies lead to the skeletal malformation syndrome campomelic dysplasia, frequently with sex reversal</p><p>The negative feedback loop between Runx2 and Sox9 is crucial for the control of chondroycte stability and hypertophic differenitation, during development and disease</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#e3896f81-1bbc-468d-bcca-ecf2d0cc85de">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2021-02-08T11:06:51Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="c44b44e6-337c-43d9-bf18-9c2f6089bae1" qual:compartment="cytosol" qual:constant="false" qual:id="S_5" qual:initialLevel="0" qual:maxLevel="1" qual:name="MMP13">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>mmp1, collagenase-3: MGI:1340026, NCBI gene: 17386</p><p>MMP13 is a matrix degrading enzyme typically secreted by hypertrophic chondrocytes. It would be one of the major actor of matrix degradation during endochondral ossification but also osteoarthritis</p><p>MMPs are produced by chondrocyte after pro-inflammatory stimuli</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#c44b44e6-337c-43d9-bf18-9c2f6089bae1">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2021-02-08T14:15:57Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="_853fe5d0-8c07-4ac6-bbe6-9587c602de37" qual:compartment="cytosol" qual:constant="false" qual:id="S_6" qual:initialLevel="0" qual:maxLevel="1" qual:name="Grem1">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>Gremlin mRNA level correlates with osteoarthritis (strongly decreased) and is regulated by osteoarthritis-associated factors. It is a natural brakes on hypertrophic differentiation in articular cartilage</p><p>Gremlin1 (Grem1): MGI:1344337, NCBI gene: 23892</p><p>Grem1 has a BMP binding kinase activity, it functions has an antagonist to BMP signalling</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#_853fe5d0-8c07-4ac6-bbe6-9587c602de37">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2019-02-05T04:22:17Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="_6b5d20b2-cb06-4433-965c-9a86ca096728" qual:compartment="cytosol" qual:constant="false" qual:id="S_7" qual:initialLevel="0" qual:maxLevel="1" qual:name="Wnt">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>WNTs are growth factors that play a vital role in proliferation and hypertrophy of chondrocytes. There are essential for joint health.</p><p>Wingless-type MMTV integration site family, several types exist; e.g. Wnt3a, MGI:98955, NCBI gene: 22416</p><p>Wnt pathway summary: The pathway is initiated bythe  binding of WNT ligands to the WNT receptor (frizzled)/co-receptor (lipoprotein receptor-related protein-LRP-5/6) complex, triggering a conformational change in the downstream molecule complex that consist of Dishevelled, adenomatosis polyposis coli (APC), axin, glycogen synthase kinase 3β (GSK3β), β-catenin, and other proteins. Through sequential changes in interaction and phosphorylation status of these proteins, phosphorylation of the amino-terminal domain of β-catenin is disturbed, leading to stabilization and nuclear translocation of β-catenin. The nuclear-translocated β-catenin stimulates transcription of the target genes with co-transcription factors such as T-cell factor/lymphoid-enhancing factor (TCF/LEF) family</p><p>Wnt is reported as a risk factor in Osteoarthritis</p><p>WNT promotes hypertrophy through activation of Runx2 transcription factor</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#_6b5d20b2-cb06-4433-965c-9a86ca096728">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2019-02-05T04:22:17Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="f3499176-ec3b-4696-a331-e1a3d9656d80" qual:compartment="cytosol" qual:constant="false" qual:id="S_8" qual:initialLevel="0" qual:maxLevel="1" qual:name="Fgfr3">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>FGFR3 and FGFR1 are the major FGF receptor isoforms expressed in human articular cartilage and the modification of a balance between the two might contribute to OA</p><p>Fgfr3 is expressed in proliferating and prehypertrophic chondrocytes and functions to inhibit postnatal chondrogenesis</p><p>MGI:95524, NCBI gene:14184</p><p>Removal of FGFR3 leads to overgrowth . activating mutations in FGFR3 account for several dysplasias such as achondrodysplasia (dawrfism)</p><p>FGFR‐3 signaling may have a chondroprotective role during the development of OA and FGFR3 expression is downregulated in articular cartilage from OA patients</p><p>Deletion of Fgfr3 in chondrorcytes leads to osteoarthritis</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#f3499176-ec3b-4696-a331-e1a3d9656d80">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2021-02-08T14:15:57Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="a895dc57-dc50-48da-a311-ebc772384f2a" qual:compartment="cytosol" qual:constant="false" qual:id="S_9" qual:initialLevel="0" qual:maxLevel="1" qual:name="Gli2">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>Glioma-associated oncogene family members (Gli1/2/3) act as a transcription factor downtream of hedgehog signalling in skeletal cells</p><p>MGI:95728 , NCBI gene:14633</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#a895dc57-dc50-48da-a311-ebc772384f2a">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2019-02-05T04:22:17Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="_8465a94a-9e87-45c7-9773-d2f1724ce4bb" qual:compartment="cytosol" qual:constant="false" qual:id="S_10" qual:initialLevel="0" qual:maxLevel="1" qual:name="FRZB">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>Frizzled-related protein (Frzb) or secreted frizzled-related protein 3 (sFRP3) : MGI:892032, NCBI gene: 20378</p><p>Frzb mRNA level negatively correlates with osteoarthritis and is regulated by osteoarthritis-associated factors. Frzb is a natural brake on hypertrophic differentiation in articular cartilage</p><p>Verapamil (overexpressing sFRP3) protects against cartilage degradation in osteoarthritis by inhibiting Wnt/β-catenin signaling</p><p>FrzB may have a protective role against cartilage degradation and MMP induction in mouse chondrocytes by attenuating deleterious effects of the activation of the canonical Wnt/β-catenin pathway.</p><p>Frzb deficient mices have reduction of  cell proliferation and differentiation in the articular cartilage - subchondral bone</p><p>"Frizzled related proteins (Frps) are secreted proteins structurally similar to frizzled receptors; they bind Wnt via the cysteine-rich domain and antagonize the Wnt signaling pathway"</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#_8465a94a-9e87-45c7-9773-d2f1724ce4bb">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2021-02-17T10:05:46Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="_8711857d-9116-4e06-b2f7-15e51c71fcf1" qual:compartment="cytosol" qual:constant="true" qual:id="S_11" qual:initialLevel="0" qual:maxLevel="1" qual:name="B-catenin">
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#_8711857d-9116-4e06-b2f7-15e51c71fcf1">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2021-02-17T13:42:48Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="a743c34f-2706-4c56-8206-75c52a413790" qual:compartment="cytosol" qual:constant="false" qual:id="S_12" qual:initialLevel="0" qual:maxLevel="1" qual:name="Col-X">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>Type collagen is one of the main component of extracellular matrix typically secreted by hypertrophic chondrocytes, contributing to cartilage mineralization during osteoarthritis</p><p>Type X collagen (col10a1): MGI:88445, NCBI gene: 12813</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#a743c34f-2706-4c56-8206-75c52a413790">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2021-02-17T13:42:48Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="_400762ff-d367-4d0a-9e05-d3b886994cac" qual:compartment="cytosol" qual:constant="false" qual:id="S_13" qual:initialLevel="0" qual:maxLevel="1" qual:name="Alk5">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>ALK5 or  transforming growth factor, beta receptor I. MGI:98728, NCBI Gene: 21812</p><p>Transduces pro-anabolic signals upong TGFbeta ligands binding.</p><p>The ration ALK5/ALK1 decreases with ageing and osteoarthritis(OA). ALK5  downstream signalling would have a protective role against OA.</p><p>Loss of ALK5 induces osteoarthritis in mouse</p><p>The node ALK5 represents the effective heterodimer of type II receptors and the ALK5  type I receptor (Type II receptors are not represented in the model</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#_400762ff-d367-4d0a-9e05-d3b886994cac">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2021-02-08T10:44:46Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="_788ca04f-46c4-4d07-bf80-f31f29ad36ce" qual:compartment="cytosol" qual:constant="false" qual:id="S_14" qual:initialLevel="0" qual:maxLevel="1" qual:name="Hif-2a">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>Hif-2alpha (hypoxic inducible factor alpha) coded by the gene Epas1, MGI:109169 , NCBI gene:13819</p><p>Hif-2alpha is induced in cartilage during hypoxia and HIF-2alpha enhanced promoter activities of COL10A1, MMP13 and VEGFA through specific binding to the respective hypoxia-responsive elements</p><p>Hif2-alpha was associated with knee osteoarthritis in genetic population study, alhtough this association was not supported by various ethnic population study as reported in (M.Nakajima et al.)</p><p>HIF2α is a catabolic transcription factor with a likely role in the osteoarthritic process. HIF2α can become activated by pro-inflammatory cytokines and stress in the avascular, hypoxic environment of articular cartilage</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#_788ca04f-46c4-4d07-bf80-f31f29ad36ce">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2019-02-05T04:22:17Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="aabc1498-61d4-416a-993f-51993de8abd4" qual:compartment="cytosol" qual:constant="false" qual:id="S_15" qual:initialLevel="0" qual:maxLevel="1" qual:name="CCND1">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>MGI:88313, NCBI gene: 12443</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#aabc1498-61d4-416a-993f-51993de8abd4">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2021-02-08T14:15:57Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="_9c63085c-f582-4f6f-bebe-d89b1224b8b7" qual:compartment="cytosol" qual:constant="false" qual:id="S_16" qual:initialLevel="0" qual:maxLevel="1" qual:name="Akt">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>Phosphoinositide‐dependent serine/threonine protein kinase Akt, also called protein kinase B (PKB)</p><p>homozygous Akt1‐deficient (Akt1−/−) mice and Akt2−/− mice show similar phenotypes, including growth retardation</p><p>Akt1 MGI:87986  NCBI Gene: 11651. Akt1 is the dominant form (among Akt1, Akt2 and Akt3) in skeletal development &amp; in chondrocyte</p><p>The Pi3K/Akt axis integrates signals from pro-catabolic and pro-anabolic stimuli and regulates seemingly opposite functions</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#_9c63085c-f582-4f6f-bebe-d89b1224b8b7">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2019-02-05T04:22:17Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="_244ad789-e536-4f14-b749-6b11c2b741a7" qual:compartment="cytosol" qual:constant="false" qual:id="S_17" qual:initialLevel="0" qual:maxLevel="1" qual:name="IkBa">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>Nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha (I(Kappa)B(alpha) or Nfkbi). MGI:104741, NCBI Gene: 18035</p><p>IκBα is a specific inhibitor of Nfkb, it  binds and sequestrate Nfkb proteins in the cytosol as well as promote its translocation outside the nucelus thereby preventing its transcriptional activity</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#_244ad789-e536-4f14-b749-6b11c2b741a7">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2021-02-08T14:04:27Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="_395068e7-a7b6-4fdd-ac8c-4f80becdcf5b" qual:compartment="cytosol" qual:constant="true" qual:id="S_18" qual:initialLevel="0" qual:maxLevel="1" qual:name="Dsh">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>The Wnt signal leads, through its receptor, to activation of Dishevelled</p><p>MGI:98297, NCBI gene: 20423</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#_395068e7-a7b6-4fdd-ac8c-4f80becdcf5b">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2019-02-05T04:22:17Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="a8d91f2d-27bc-4c26-9879-1c4d12b9bee3" qual:compartment="cytosol" qual:constant="false" qual:id="S_19" qual:initialLevel="0" qual:maxLevel="1" qual:name="PPR">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>PPR or pth1r, parathyroid hormone 1 receptor. MGI:97801 , NCBI gene19228</p><p>PTH/PTHrP receptor (PPR). Membranar receptor expressed by chondroctes and to which PThrP binds. Expression of this receptor will define if a cell is sensitive to PThrP signalling. PPR is expressed in pre-hypertrophic chondrocyte in the GP</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#a8d91f2d-27bc-4c26-9879-1c4d12b9bee3">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2019-02-05T04:22:17Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="c88ab673-3012-498d-9125-8617288402bf" qual:compartment="cytosol" qual:constant="true" qual:id="S_20" qual:initialLevel="0" qual:maxLevel="1" qual:name="Destruction complex">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>When the wnt pathway is off, the transcriptional coactivator β-catenin is degraded by a multiprotein "destruction complex" that includes the tumor suppressors Axin and adenomatous polyposis coli (APC), the Ser/Thr kinases GSK-3 and CK1, protein phosphatase 2A (PP2A), and the E3-ubiquitin ligase β-TrCP.</p><p>Complex formed with GSK3beta (MGI:1861437) and other molecules</p><p>the transcriptional coactivator β-catenin is degraded by a multiprotein "destruction complex" that includes the tumor suppressors Axin and adenomatous polyposis coli (APC), the Ser/Thr kinases GSK-3 and CK1, protein phosphatase 2A (PP2A), and the E3-ubiquitin ligase β-TrCP.</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#c88ab673-3012-498d-9125-8617288402bf">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2019-02-05T04:22:17Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="_14093af4-ce72-49b3-9b71-dae38118d76f" qual:compartment="cytosol" qual:constant="false" qual:id="S_21" qual:initialLevel="0" qual:maxLevel="1" qual:name="Lef/tcf">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>When the Wnt pathway is activated LEF/TCF direclty bind to the Runx2 promotor to activate Runx2 transcription.</p><p>Tcf7:  MGI:98507; ncbi gene: 21414</p><p>LEF and TCF7 are transcription factors downstream of Wnt pathway. They regulate the experssion of Wnt targets.</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#_14093af4-ce72-49b3-9b71-dae38118d76f">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2021-02-08T14:15:57Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="b9b08e35-8362-4faf-b0b7-54b61968125d" qual:compartment="cytosol" qual:constant="false" qual:id="S_22" qual:initialLevel="0" qual:maxLevel="1" qual:name="BMP">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>Bone Morphogenic proteins are important factors regulating chondrogenesis and skeletogenesis during normal embryonic development</p><p>In growth plate BMP2 and 6 are not expressed in proliferative chondrocytes and the level rise till hypetrophy.</p><p>Overexpression of BMP2 was found in osteoarthritis tissues</p><p>e.g. Bmp2, MGI:88177; NCBI gene: 12156</p><p>The downstream effect of BMP ligands depends on the receptors they bind to. The model only includes a subset of potential  downstream effects (noth canonical and non canonical)</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#b9b08e35-8362-4faf-b0b7-54b61968125d">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2019-02-05T04:22:17Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="_3b018108-7d60-43c8-a833-eb54f1f2ee7b" qual:compartment="cytosol" qual:constant="false" qual:id="S_23" qual:initialLevel="0" qual:maxLevel="1" qual:name="p38">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>p28 or mitogen-activated protein kinase 14 (Mapk14) MGI:1346865, NCBI gene: 26416</p><p>p38 are mammalian MAPKs activated by the upstream kinases MKK3 and MKK6. p38 phosphorylation is increased during chondrogenisis and inhibition of p38activity blocks chondrogenisis</p><p>Phosphorylation of p38 is higher in human OA compared to normal tissue and p38inhibitor was investigated as potential OA treatment</p><p>It may be involved in the control of the Sox9 function during chondrogensis via the BMP‐2/p38 pathway.</p><p>p38 has important effects on chondroycte maturation and may be o potential target for OA therapies but its exact role remains controversial as it is located at the crosstalk of several pathways</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#_3b018108-7d60-43c8-a833-eb54f1f2ee7b">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2021-02-17T13:37:18Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="e8132847-f006-4fba-ad4d-6aeaacafe878" qual:compartment="cytosol" qual:constant="false" qual:id="S_24" qual:initialLevel="0" qual:maxLevel="1" qual:name="IGF-IR">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>Insulin growth factor receptor (Igf1r): MGI:96433, NCBI gene:16001</p><p>Ligand binding leads to the IGF-I receptor phosphorylation, subsequently activating its tyrosine kinase activity.</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#e8132847-f006-4fba-ad4d-6aeaacafe878">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2021-02-18T12:53:50Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="e6e0626b-be1c-41f6-a8f1-2513969dfb75" qual:compartment="cytosol" qual:constant="true" qual:id="S_25" qual:initialLevel="0" qual:maxLevel="1" qual:name="Smad Complex">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>Smad-complex denotes a complex formed of R-Smads and Smad4. The resulting complex has a transcriptional activity in the nucleus.</p><p>It is part of the Bmp canonical pathway but it is also regulated by TGB-beta in articular chondrocytes</p><p>Smad4: MGI:894293, NCBI gene: 17128</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#e6e0626b-be1c-41f6-a8f1-2513969dfb75">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2021-02-05T12:44:15Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="_3bdbfa89-a8ff-420b-bdbb-a374401fec85" qual:compartment="cytosol" qual:constant="false" qual:id="S_26" qual:initialLevel="0" qual:maxLevel="1" qual:name="Alk1">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>Upon ligand binding, they tranduces signal via phosphorylation of downstream proteins, such as Smads. They would promote rather pro-catabolic pathways and an increase of ALK1 amount and expression was obserged in ageing population and OA.</p><p>Activin A receptor, type II-like 1. Acvrl1, MGI:1338946, NCBI Gene: 11482</p><p>Receptors of the TGF super familly, they normally function in dimers and may be activated both by TGF-beta of BMPs</p><p>Upon type I receptor activation (Alk1), intracellular signalling is initiated by C-terminal phosphorylation of receptor-regulated (R)-SMAD proteins. Whereas ALK5 stimulates phosphorylation of SMAD2 and SMAD3, ALK1 mediates the activation of SMAD1, SMAD5 and SMAD8. Phosphorylated R-SMADs form heteromeric complexes (trimers) with SMAD4, the common mediator SMAD (co-SMAD); the trimers are made up of two R-SMADs and one SMAD4. These heteromeric complexes accumulate in the nucleus where they, together with co-activators and repressors, control transcriptional responses.  Frequently, these two main intracellular SMAD pathways are found to antagonize each other</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#_3bdbfa89-a8ff-420b-bdbb-a374401fec85">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2021-02-08T10:44:46Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="_3683dc01-0f16-42cc-b6ff-4918810863af" qual:compartment="cytosol" qual:constant="false" qual:id="S_27" qual:initialLevel="0" qual:maxLevel="1" qual:name="Mef2C">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>Myocyte enhancer factor 2C (Mef2c): MGI:99458, NCBI gene:17260</p><p>Among the 4 mammal MEF2 genes, MEF2C have been shown to have an important role in bone development</p><p>MEF2C is expressed in (pre)hypertrophic chondrocyte promote expression, at the transcriptional level, of genes related to hypertrophy such as Col-X</p><p>MEF2C operates upstream of Runx2 in chondrocyte hypertrophy and that is it directly or indirectly responsible for its expression.</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#_3683dc01-0f16-42cc-b6ff-4918810863af">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2021-02-15T13:27:23Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="_2c3b88b5-2996-4126-af98-c0f3b9bffe8a" qual:compartment="cytosol" qual:constant="false" qual:id="S_28" qual:initialLevel="0" qual:maxLevel="1" qual:name="Fgfr1">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>FGFR1 is expressed in hypetrophic chondrocytes and tabecular bone</p><p>FGFR3 and FGFR1 are the major FGF receptor isoforms expressed in human articular cartilage and the modification of a balance between the two might contribute to OA</p><p>FGFR1 inhibitors protect against cartilage degradation in a murine model of osteoarthritis</p><p>fgfr1 (FGF receptor 1) MGI:95522 , NCBI gene:14182</p><p>Fgfr1 promotes osteoarthitis in articular cartilage. Loss of Fgfr1 reduces hypertophic differentiation</p><p>FGF2 pro-anabolic effect on cartilage would be transduced by FGFR1</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#_2c3b88b5-2996-4126-af98-c0f3b9bffe8a">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2021-02-08T14:04:27Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="_04f80225-2cc4-4f3f-8313-30a362e3b4ed" qual:compartment="cytosol" qual:constant="false" qual:id="S_29" qual:initialLevel="0" qual:maxLevel="1" qual:name="Col-II">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>Type II collagen (col2a1): MGI:88452, NCBI gene:12824</p><p>Type II collagen is one of the major component of extracellular matrix (ECM) surrounding proliferative or stable chondrocytes, it amount to 15–22% of the ECM by wet weight</p><p>Collagen is present in the shape of fibers in the pericellular and extracellular cartilage matrix. One of the hallmark of osteoarthritis is the replacement of type II collagen by other types, sucha as type X collagen secreted by hypertophic chondrocytes.</p><p>The so called "Type II" collagen in cartilage is really a  type II, IX and XI combo of fibers</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#_04f80225-2cc4-4f3f-8313-30a362e3b4ed">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2021-02-17T13:42:48Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="_7bd5235a-f82b-4090-867c-5dfb2088e04c" qual:compartment="cytosol" qual:constant="false" qual:id="S_30" qual:initialLevel="0" qual:maxLevel="1" qual:name="Proteoglycans">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>gene: Aggrecan Acan (or Agc1). MGI:99602, NCBI Gene: 11595</p><p>Proteoglycans are proteins that have been functionalized by some glycans. Aggrecans are the major type of proteoglycans in the articular cartilage</p><p>Proteoglycans are among the main constituents of the ECM, secreted by chondrocytes, they provide to cartilage its hydrogel property, which is essential for the load-bearing function of the knee joint.</p><p>Loss of proteoglycans is one of the hallmark of osteoarthritis</p><p>They provide to cartilage its load bearing function and biomechanical properties</p><p>Proteglycans give to articulat cartilage its ability to resist compressive loads</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#_7bd5235a-f82b-4090-867c-5dfb2088e04c">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2021-02-08T11:06:51Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="c737e3f2-f7a2-44b1-b035-1787aedc44e0" qual:compartment="cytosol" qual:constant="false" qual:id="S_31" qual:initialLevel="0" qual:maxLevel="1" qual:name="ERK1/2">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>Mitogen-activated protein kinase ERK2: Mapk1: MGI:1346858, NCBI gene: 26413</p><p>Mitogen-activated protein kinase or extracellular signal-regulated kinase. ERK1: Mapk3: MGI:1346859, NCBI gene: 26417</p><p>It is a signaling kinase protein transducing signals in the MAPK signalling pathways. It stands at the end of the cascade to phosphorylate and thereby activate various transcription factors.</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#c737e3f2-f7a2-44b1-b035-1787aedc44e0">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2021-02-15T16:24:18Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="_6b61a0c7-a529-4ace-bdd2-a57af28fb1ea" qual:compartment="cytosol" qual:constant="true" qual:id="S_32" qual:initialLevel="0" qual:maxLevel="1" qual:name="ATF2">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>Activating transcription factor 2 (Atf2 or Creb2): MGI:109349 , NCBI gene:11909</p><p>ATF2 also called CRE-BP1, CREB2, is a cAMP response element (CRE). It has a transcriptional activity and acts downstream  of the TGF-β  pathway</p><p>ATF-2 activation inhibits chondrocyte hypertrophy in mouse articular cartilage</p><p>The transcriptional responses to the JNK signal transduction pathway is mediated by ATF2</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#_6b61a0c7-a529-4ace-bdd2-a57af28fb1ea">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2021-02-17T10:05:46Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="_7c2cf3cc-9610-4e6b-bda0-b7c666e2975d" qual:compartment="cytosol" qual:constant="false" qual:id="S_33" qual:initialLevel="0" qual:maxLevel="1" qual:name="FGF">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>FGF2 was identified as a degenerative mediator (promote catabolism) in Osteoarthritis, although its exact role is controversial</p><p>Fribroblast Growth factor ligands e.g. fgf18 (shown to bind fgfr3 and promote chondrogenisis). MGI:1277980 , NCBI gene:14172</p><p>FGFs 2, 9 and in particular FGF18 together with the receptors FGFR1 and 3 are implicated in growth plate development.</p><p>Via receptor activation, FGF ligands signal through various transduction pathways such as Ras/Raf/MEK/MAPK, PI3k/Akt, STAT1,</p><p>Fribroblast Growth factor signalling is essential for skeletal development as was first put in evidence with FGFR mutation associated bone morphongenic disorder such as achondroplasia (dwarfism)</p><p>Different FGF ligands have been shown to preferientially bind to different receptors and activate differential responses. For sake of simplification, only a global FGF node was introduce in the current model, however, making the dinstinction between FGF2 and FGF18 ligands, for example, might be important and subject to future imrpovments.</p><p>The pro-anabolic or pro-catabolic nature of FGF ligands depends on the receptors mediating the signal, blocking on type of receptor has emerged as potential therapeutic strategy to tip the role of FGF signaling during OA</p><p>Using recombinant FGF18 migh be good therapeutic strategy against osteoarthritis as was demonstrated by several clinical trials</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#_7c2cf3cc-9610-4e6b-bda0-b7c666e2975d">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2019-02-05T04:22:17Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="b71b1d51-1986-4e2a-b992-0b4a872ec886" qual:compartment="cytosol" qual:constant="false" qual:id="S_34" qual:initialLevel="0" qual:maxLevel="1" qual:name="PP2A">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>It is involved in the regulation of several important regulators of chondrocyte maturation (HDAC4, AKT, ERK1/2, etc..) and also involved in the formation of the destruction complex within the Wnt/beta-catenin pathway</p><p>Direct messenger of PKA downstream of the PTHrP growth factor. It is a negative regulator of ERK and AKT</p><p>Protein phosphatase 2 (formerly 2A) (Ppp2ca) MGI:1321159, NCBI gene: 19052</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#b71b1d51-1986-4e2a-b992-0b4a872ec886">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2021-02-09T10:01:02Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="b757c7ce-e0b1-408c-bb40-50b8746833ef" qual:compartment="cytosol" qual:constant="true" qual:id="S_35" qual:initialLevel="0" qual:maxLevel="1" qual:name="PKA">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>cAMP/protein kinase A (Prkaca), MGI:97592, NCBI gene: 18747</p><p>PKA is a protein kinase and CREB is a prototypical PKA downstream transcription factor transducing PKA signalling in the nucleus. CREB is not represented in the model since it would be linearly downstream of PKA, its nuclear action is directly operated by PKA in the model</p><p>cAMP dependent protein kinase (PKA) is involed in PTHrP signalling, it tranduces the signal by phosphorylation of the downstream targets</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#b757c7ce-e0b1-408c-bb40-50b8746833ef">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2019-05-08T10:27:44Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="_63297473-8b5f-4bc3-86f5-ae46ac57979d" qual:compartment="cytosol" qual:constant="false" qual:id="S_36" qual:initialLevel="0" qual:maxLevel="1" qual:name="d-EF1">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>This gene encodes a zinc finger transcription factor. It can act as positive or negative transcriptional regulator</p><p>[delta]-EF1 or Zeb1. MGI:1344313, NCBI gene:: 21417</p><p>Zeb1 is expressed in cartiage and is increased in osteoarthritic patients, it may be contribute to chondrocyte hypertophy and OA.</p><p>d-EF1 (or Zeb1) play a central role in the decrease of collagen II and cartilage matrix production</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#_63297473-8b5f-4bc3-86f5-ae46ac57979d">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2021-02-17T17:32:04Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="_1618082a-a488-4ffc-a659-96fa9583689a" qual:compartment="cytosol" qual:constant="true" qual:id="S_37" qual:initialLevel="0" qual:maxLevel="1" qual:name="HDAC4">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>Overexpression of HDAC4 in proliferating chondrocytes, in vivo, inhibits  hypertrophy and differentiation.</p><p>Histone deacetylase 4: MGI:3036234, NCBI gene:208727</p><p>Histone deacetylases (HDACs) modulate cell growth and differentiation by governing chromatin structure and repressing the activity of specific transcription factors. HDAC4 affects transcription fators access to DNA</p><p>"Acetylation of lysine residues within histone protein tails reduces their affinity for DNA, thereby relaxing the chromatin structure and increasing the accessibility of DNA to transcription factor. [...] Histone deacetylases (HDACs) are capable of reversing this process by removing the acetyl moiety and, therefore, allowing histones to bind tightly to DNA again"</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#_1618082a-a488-4ffc-a659-96fa9583689a">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2019-02-05T04:22:17Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="_0c3900a3-1694-45f9-a59e-da6ae571afbf" qual:compartment="cytosol" qual:constant="true" qual:id="S_38" qual:initialLevel="0" qual:maxLevel="1" qual:name="ATF4">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>Activating transcription factor 4 (Atf4). Also known as AP-1 or CREB, MGI:88096, NCBI gene: 11911</p><p>ATF4 is a leucine-zipper-containing protein of the cAMP response element-binding protein (CREB) family. Ablation of Atf4 (Atf4−/−) in mice leads to severe skeletal defects, including delayed ossification and low bone mass, short stature and short limbs. Atf4 is expressed in proliferative and prehypertrophic growth plate and articular chondrocytes</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#_0c3900a3-1694-45f9-a59e-da6ae571afbf">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2021-02-05T10:53:21Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="dd377709-176e-4b32-8fa8-deed389d5f62" qual:compartment="cytosol" qual:constant="true" qual:id="S_39" qual:initialLevel="0" qual:maxLevel="1" qual:name="Frizzled-LRP5/6">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>LRP5: MGI:1278315  NCBI Gene: 16973. / LRP6: MGI:1298218  NCBI Gene: 16974.</p><p>Frizzled-LRP5/6 represents the (frizzled)/co-receptor (lipoprotein receptor-related protein-LRP-5/6) complex</p><p>The Wnt pathway is activated by binding of WNT to Frizzled family receptors</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#dd377709-176e-4b32-8fa8-deed389d5f62">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2019-02-05T04:22:17Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="df6f9f4a-02f3-4dee-945b-36176c015dd3" qual:compartment="cytosol" qual:constant="false" qual:id="S_40" qual:initialLevel="0" qual:maxLevel="1" qual:name="IGFI">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>Insulin-like Growth Factor 1 (Igf1, IGF-I). MGI:96432, NCBI gene:16000</p><p>Insulin-like Growth Factor 1, IGF1 is involved in metabolism regulation and is very important for growth during development.</p><p>There is a complex and cell stage-specific anabolic action of IGF-I in the growth plate</p><p>In articular chondrocytes, IGF-I regulates differentiation, maintenance of the differentiated phenotype, and apoptosis via a PI-3 kinase pathway that modulates ERK, p38 kinase, and PKC signaling</p><p>IGF-I is know is able to promote cartilage matrix production. Even though it was reported ot be overexpressed in osteoarthritis (OA), its bio-availability at the protein level is curtailed by other factors during OA</p><p>IGF-I signalling is an important driver of cartilage anabolism and, disturbance of this pathway could be related to osteoarthritis</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#df6f9f4a-02f3-4dee-945b-36176c015dd3">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2019-02-05T04:22:17Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="_707d4298-4af7-454b-bcba-5ea727bb1e2b" qual:compartment="cytosol" qual:constant="false" qual:id="S_41" qual:initialLevel="0" qual:maxLevel="1" qual:name="Ihh">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>Ihh is involved in a major feedback loop with PthrP to regulate chondrocyte differentiation in the growth plate. Ihh stimulates the production of PTHrP and thereby delays chondrocyte hypertrophy. Overall it is major regulator on chondrocyte phenotype</p><p>MGI:96533, NCBI gene:16147</p><p>Hedgehog (Hh) signalling pathway has critical function in bone formation. In particular Indian Hedgehog (Ihh) has an essential function in endochondral ossification</p><p>IHH-PTHrP would also participate in the maintenance of articular cartilage. Dysregulation of this system might contribute to the pathogenesis of arthritis.</p><p>Ihh is normally upregulated togehter with Runx2 in (pre)hypertophic chondrocytes</p><p>Modulating Ihh signalling would be a therapeurical strategy for osteoarthritis</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#_707d4298-4af7-454b-bcba-5ea727bb1e2b">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2022-07-27T07:31:56Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="_149e6058-d68c-40ea-9c37-d9e485bb0439" qual:compartment="cytosol" qual:constant="true" qual:id="S_42" qual:initialLevel="0" qual:maxLevel="1" qual:name="Stat1">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>signal transducer and activator of transcription-1 (STAT1) MGI:103063 , NCBI gene:20846</p><p>Stat1 is located downstream of FGF pathway and control expression of target genes in the nucleus. FGF control chondrocyte proliferation in part through STAT1</p><p>STAT1-p21 signalling mediates the inhibitory effects of FGFR3 on endochondral ossification &amp; in pathological conditions</p><p>STAT1 has a transcriptional activity in the nucleus in the form of homodimers</p><p>STAT proteins are activated by phosphorylation thanks to JAK kinases. Intermediary JAK are not represented in the model for reason of simplification. The Stat1 in the model represents JAK/Stat1 pathway.</p><p>Stat1 is upregulated in rheumatoid arthritis and osteoarthritis</p><p>STAT1, originally identified as a signal transducing molecule in the interferon (IFN) pathway, is activated by tyrosine phosphorylation to dimerize and translocate into the nucleus where it then functions as a transcriptional regulator</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#_149e6058-d68c-40ea-9c37-d9e485bb0439">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2021-02-18T12:53:50Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="_07318145-690e-410e-b21f-5503d188299f" qual:compartment="cytosol" qual:constant="false" qual:id="S_43" qual:initialLevel="0" qual:maxLevel="1" qual:name="DKK1">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>dickkopf 1 homolog (Dkk1). MGI:1329040, NCBI gene: 13380</p><p>DKK1 mRNA level negatively correlates with osteoarthritis and is regulated by osteoarthritis-associated factors. Dkk1 is a natural brake on hypertrophic differentiation in articular cartilage</p><p>dickkopf 1 homolog (DKK1) is a Wnt antagonist</p><p>Antagonizes canonical Wnt signaling by inhibiting LRP5/6 interaction with Wnt and by forming a ternary complex with the transmembrane protein KREMEN that promotes internalization of LRP5/6</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#_07318145-690e-410e-b21f-5503d188299f">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2021-02-17T10:05:46Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="_4d75685d-fbb0-4a61-9a44-42371c2eb1f2" qual:compartment="cytosol" qual:constant="false" qual:id="S_44" qual:initialLevel="0" qual:maxLevel="1" qual:name="Runx2">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>MGI:99829, NCBI gene: 12393</p><p>Runx2 is a master transcription factor for hypertophy during endochondral ossification and it may play a important role in the development of osteoarthritis too</p><p>Runt-related transcription factor 2; Transcription factor involved in osteoblastic differentiation and skeletal morphogenesis. Essential for both intramembranous and endochondral ossification.</p><p>Also called Cbfa1 , PEBP2A or Osf2. Disease association database: OMIM600211</p><p>The negative feedback loop between Runx2 and Sox9 is crucial for the control of chondroycte stability and hypertophic differenitation, during development and disease</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#_4d75685d-fbb0-4a61-9a44-42371c2eb1f2">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2021-02-17T16:03:18Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="_93f2bf51-f022-4949-8ad0-3cfc75d51d8a" qual:compartment="cytosol" qual:constant="false" qual:id="S_45" qual:initialLevel="0" qual:maxLevel="1" qual:name="Msx2">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>mesh-less homeobox 2 (Msx2) Synonym: hox8. MGI:97169, NCBI gene:17702</p><p>Variation of Msx2 expression was shown to be associated with osteoarthritis</p><p>mesh-less 2 (Msx2) is expressed in resting and proliferating chondrocytes. Msx2−/− mice show, in addition to other phenotypes, defects in both endochondral and intramembranous ossification</p><p>Msx2 is an homeobox protein. Homeobox proteins are transcription factors that direct proper development by regulating specific temporal and spatial patterns of gene expression</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#_93f2bf51-f022-4949-8ad0-3cfc75d51d8a">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2019-02-05T04:22:17Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="_83346631-ec27-4500-967d-932d7cb9071e" qual:compartment="cytosol" qual:constant="false" qual:id="S_46" qual:initialLevel="0" qual:maxLevel="1" qual:name="R-Smad">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>Smad3/5/9. E.g. Smad5: MGI:1328787, NCBI gene:17129</p><p>receptor-activated Smads (R-smad) are activated when BMP binds to its membranar receptor and they associate with Smad4 to form the Smad-complex, which has a transcriptional activity in the nucleus and transduces BMP signal.</p><p>R-smads are Smad3/5/8 in human and Smad3/5/8 in mouse.</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#_83346631-ec27-4500-967d-932d7cb9071e">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2021-02-17T17:32:04Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="_308d20ca-57a5-4e29-98f6-79332f380a07" qual:compartment="cytosol" qual:constant="true" qual:id="S_47" qual:initialLevel="0" qual:maxLevel="1" qual:name="TAK1">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>TGF-β-activating kinase (TAK1 or Map3k7). MGI:1346877. NCBI Gene: 26409</p><p>After binding to membrane receptors (e.g. Toll-like receptors for Il-B), a kinases phosphorylation cascade takes place involving IRAK and TGF-β-activating kinase (TAK1), this linear transduction is summarized under the node TAK1 in the model  Downstream of TAK1, pro-inflammatory  stimuli are transduced via different pathways involving p38, ERK1/2, JNK and  Nf-kB</p><p>Pro-inflammatory cytokine pathways converge towards the activaction of TAK1 (via IRAK and other intermediraies not represented here)</p><p>TAK1 is activated by cascades of ubiquitinationa and phosphorylation</p><p>Tak1 is essential for articular cartilage, notably because it is able to regulate SOX9 expression (indirectly)</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#_308d20ca-57a5-4e29-98f6-79332f380a07">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2021-02-08T10:59:13Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="_31effbc2-defa-4abc-b2f5-ca1687208020" qual:compartment="cytosol" qual:constant="true" qual:id="S_48" qual:initialLevel="0" qual:maxLevel="1" qual:name="Smad3">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>The TGF-beta/Smad3 axis promotes pro-anabolic signals and tend to prevent chondrocyte hypertrophy. One of the mode of action might the recruitment of HDAC4 deacetylase to limit Runx2 transcriptional activity</p><p>Smad3: MGI:1201674, NCBI gene: 17127</p><p>Dysregulation of Smad3 signal might be involved in both onset and progression of OA. Smad3−/− mice gradually developed an end-stage OA phenotype</p><p>Smad3 transduce TGF-beta signal in chondrocyte</p><p>Smad3/Smad2 transduce TGFβ signal in chondrocyte. In presence of TGFβ, Smad3 complexes with co-Smad4 and translocate in the nucleus where it has a transcriptional activity</p><p>Smad2 and Smad3 are considered to have similar funcitons in a number of context including cartilage and were represented as a single node in the model for sake of simplification</p><p>Smad2 and Smad3 interact with a variety of DNA-binding proteins (e.g. HDAC4) in different contexts, thereby modulation the activity of other transcriptional regulators</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#_31effbc2-defa-4abc-b2f5-ca1687208020">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2021-02-17T17:23:21Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="fc31d220-51d5-433b-a974-869f7c0da857" qual:compartment="cytosol" qual:constant="false" qual:id="S_49" qual:initialLevel="0" qual:maxLevel="1" qual:name="Smad7">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>Inhibitory Smads are Smad6 and Smad7. Smad7 inhbits BMPs and TGF-βs signal in multiple ways: preventing R-Smad nuclei translocation, competitively binding with type I receptor to prevent R-Smad phosphorylation, and promoting R-smads or receptor degradation by recruiting E3 ubiquitin ligases Smurf1/2</p><p>Inhibitory Smad. MGI:1100518, NCBI gene:17131</p><p>Conditional-overexpression of Smad7 in MSC or stage-specific chondrocytes results in defective mesenchymal condensation, chondrocyte proliferation and chondrocyte maturation, respectively</p><p>TGF-β superfamily ligands can induce expression of the I-Smads, suggesting that these Smads act as part of an autocrine negative feedback loop</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#fc31d220-51d5-433b-a974-869f7c0da857">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2019-02-05T04:22:17Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="_991f72e8-3185-4038-9acf-a9a062371c5f" qual:compartment="cytosol" qual:constant="false" qual:id="S_50" qual:initialLevel="0" qual:maxLevel="1" qual:name="Nkx3.2">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>NK3 homeobox 2 (nkx3-2), also called Bapx1: MGI:108015, NCBI gene: 12020</p><p>Nkx3.2 is an homeobox protein, therefore it has a transcriptional activity. It is strongly involved int he process of endochondral ossification. It notably act concomitantly with Sox9 to repress the expression of Runx2. It is a negative regulator of chondrocyte maturation</p><p>Overexpression of Nkx3.2 promotes and inhibition of Nkx3.2 suppresses chondrogenic differentiation. It promotes Col-II and GAG epxression.</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#_991f72e8-3185-4038-9acf-a9a062371c5f">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2019-05-08T10:27:44Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="fec1cc13-7ed2-4050-94e0-54452e13130f" qual:compartment="cytosol" qual:constant="false" qual:id="S_51" qual:initialLevel="0" qual:maxLevel="1" qual:name="Infl. cytokines">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>Several pro-inflammatory cytokines can be senses by chondrocytes and activate downstream pathways, this node represent typical cytokines such as IL-1 aof TNF-alpha with generic pro-inflammatory pathways without making distinctions for the subtility of each kind of pro-inflammatory cytokines</p><p>Pro-inflammatory cytokines such as interleukin-1β (IL-1B) or TNF-α (TNF-alpha)</p><p>Even though osteoarthrtis is not a typical inflammatory disease (low synovitis grade), several pro-inflammatory pathways are overactivated in that disease and play an important role cartilage physiology</p><p>Pro-inflammatory cytokines upregulate catabolic processes, ECM degrading enzymes and other pro-inflammatory mediator, which constitutes a feedforward loop</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#fec1cc13-7ed2-4050-94e0-54452e13130f">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2021-02-08T11:06:51Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="_613b0c3c-3d6b-483a-8c5f-4be0d7ef9e24" qual:compartment="cytosol" qual:constant="true" qual:id="S_52" qual:initialLevel="0" qual:maxLevel="1" qual:name="Elk1">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>These transcription factors regulate numerous target genes alone or in collaboration with other factors</p><p>Ets1, the founding member of the Ets transcription factor family is involved in several developmental processes. It also controls expression of cytokine and chemokine genes (Uniprot).</p><p>Ets Familly (Elk1) NCBI Gene: 13712 /  (Ets1) MGI:95455, NCBI gene: 23871</p><p>They are transcription factors acting downstream of MAPK signalling. In particular they are activated by ERK1/2</p><p>For instance Elk-1 (NCBI Gene: 13712) is part of the Ets familly of transcription factors and transduces signals downtsream of MAPK to the nucleus. We consider Ets1 and Elk1 redundant in this model</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#_613b0c3c-3d6b-483a-8c5f-4be0d7ef9e24">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2021-02-08T14:15:57Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="e9e7c5e3-ec83-4855-a4ea-1ba1fd457dc7" qual:compartment="cytosol" qual:constant="true" qual:id="S_53" qual:initialLevel="0" qual:maxLevel="1" qual:name="JNK">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>c-Jun N-terminal kinase (JNK) or mitogen-activated protein kinase 8 (Mapk8). MGI:1346861. NCBI Gene: 26419</p><p>It is a signaling kinase protein transducing signals in the MAPK signalling pathways together with ERK1/3 and p38. It stands at the end of the cascade to phosphorylate and thereby activate various transcription factors.</p><p>It is involved in the transduction of pro-inflammatory signals and the downstream transcriptional effectors represented in the model are Elk1/Ets and ATF2</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#e9e7c5e3-ec83-4855-a4ea-1ba1fd457dc7">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2021-02-08T11:06:51Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="f1770e9c-7f22-4968-8e52-d35ef5e7b0a0" qual:compartment="cytosol" qual:constant="false" qual:id="S_54" qual:initialLevel="0" qual:maxLevel="1" qual:name="R_inflam">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>Receptor of inflammatory cytokines, e.g: Toll-like receptors for IL-beta or TNA-alpha</p><p>Most Pro-inflammatory cytokine activated pathways converge in the activation of the TAK1 kinase. This kinase is able to subsequently activate several pathways including ERK1/2/MAPK and NfkB related pathway. TAK1 unlock NfkB transcriptional activity via inhibtion of IkBa, a NfkB specific inhibitor.</p><p>Downstream target genes include ECM degrading enzymes (e.g. ADMATS5, MMP13) but gene coding for pro-inflammatory cytokines, which constitute a feedforward loop.</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#f1770e9c-7f22-4968-8e52-d35ef5e7b0a0">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2021-02-08T19:35:29Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="_3688031a-1406-4d5f-ad97-0bd39bc0e9d1" qual:compartment="cytosol" qual:constant="true" qual:id="S_55" qual:initialLevel="0" qual:maxLevel="1" qual:name="NFkB">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>NfkB is central in the intracellular transduction on pro-inflammatory signals.</p><p>Nuclear factor of kappa light polypeptide gene enhancer in B cells (NFkb1 or p50: MGI:97312 , NCBI gene:18033) / (Rela/p65 : NCBI: 19697)</p><p>NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52</p><p>NF-κB regulates the expression of many cytokines and chemokines, adhesion molecules, inflammatory mediators, and several matrix degrading enzymes</p><p>NfkB is involved in the pathophysiology of osteoarthritis</p><p>Nfkb is activated following pro-inflammatory signal sensing by the cells. It is key in transducing the downstream signals: TAK1 activates nuclear factor B (IκB) kinase 2 (IKK2), which phosphorylates ΙκΒα, the inhibitor of NF-κB, thereby fixing it on proteosomal degradation. Whent he inhibitor of Nfkb is degraded, the transcription factor is free to translocate to the nucleus and actiavted downstream targets sucha as Mmp13, Hih2a, Ihh, etc..</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#_3688031a-1406-4d5f-ad97-0bd39bc0e9d1">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2021-02-16T12:04:39Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="dee72b8b-7db6-4932-8e6c-fb78aa9b4968" qual:compartment="cytosol" qual:constant="false" qual:id="S_56" qual:initialLevel="0" qual:maxLevel="1" qual:name="SOCS">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>Suppressors of cytokine signaling -1 (Socs1). MGI:1354910, NCBI Gene: 12703</p><p>SOCS are soluble inhibitors of  pro-inflammatory cytokines receptors, they prevent the downstream phosphorylation cascades.</p><p>They also negatively regulate the JAK/STAT pathway during osteoarthritis</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#dee72b8b-7db6-4932-8e6c-fb78aa9b4968">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2021-02-08T14:15:57Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="_2768147a-e1e5-43f5-95ad-cc4e3745be3d" qual:compartment="cytosol" qual:constant="false" qual:id="S_57" qual:initialLevel="0" qual:maxLevel="1" qual:name="PTHrP">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>Pthlh, parathyroid hormone-like peptide, MGI:97800, NCBI gene:19227</p><p>Pathway Summary: PTHrP is a secreted factor that signals through PPR to activate PKA, Ca2+ transients and PKC pathways. Activation of the PTH/PTHrP receptor leads to activation of multiple G proteins. The activation of Gs leads to subsequent activation of adenylate cyclase and generation of cyclic AMP (cAMP). cAMP will then activate PKA, which will in turn phosphorylate Sox9, greatly increasing its activity.</p><p>PTHrP/PThrP receptor signalling breaks down hypertophy in chondrocytes and are involved in a Ihh/PthrP feedback loop controlling chondrocyte differentiation</p><p>PTHrP siganlling prevents premature chondrocyte hypertrophy notably by promoting Runx2 degradation. It also showed potential to inhibit hypertrophy in articular chondrocytes</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#_2768147a-e1e5-43f5-95ad-cc4e3745be3d">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2019-02-05T04:22:17Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="a3a0c96a-2879-4f2a-a315-04702cf28d0e" qual:compartment="cytosol" qual:constant="true" qual:id="S_58" qual:initialLevel="0" qual:maxLevel="1" qual:name="GSK3beta">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>Glycogen synthase kinase 3 beta is  is a multifunctional serine/threonine kinase found in all eukaryotes. It is involved in several cellular signalling pathways where it controls activity of downtream factors including transcription factors</p><p>Proxy for free GSK3beta (= GSK3B not included in Destruction complex). So it represent the activity of GSK3beta in other signalling parhway than the Wnt/Bcat one.</p><p>MGI:1861437, NCBI gene: 56637</p><p>MGI:1861437, NCBI gene: 56637</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#a3a0c96a-2879-4f2a-a315-04702cf28d0e">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2019-02-05T04:22:17Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="_82c2665f-7f9d-406f-a119-ab5ca6811a27" qual:compartment="cytosol" qual:constant="false" qual:id="S_59" qual:initialLevel="0" qual:maxLevel="1" qual:name="PI3K">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>The PI3K pathway control hypetrophic differentiation during endochondral ossification.  PI3K inhibition reduces the length of the proliferating and particularly of the hypertrophic zone</p><p>Phosphatidylinositol 3-kinase (pi3kr1). MGI:97583, NCBI gene: 18708</p><p>the Pi3k/Akt axis lies at the crossroad of several pathways hence it potential dual role, depending on the cellular context and environement. For instance, pro-inflammatoiry cytokines, produced during OA, are able to activate that axis.</p><p>The Pi3K/Akt axis integrates signals from pro-catabolic and pro-anabolic stimuli and regulates seemingly opposite functions</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#_82c2665f-7f9d-406f-a119-ab5ca6811a27">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2021-02-17T16:03:18Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
      <qual:qualitativeSpecies metaid="b6ce15ee-69e7-4196-a75f-8cc7e7f0222d" qual:compartment="cytosol" qual:constant="false" qual:id="S_60" qual:initialLevel="0" qual:maxLevel="1" qual:name="TGF-beta">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>TGF-beta plays a key role in chondrocyte hypertophy and cartilage homeostasis. Modification of this pathway may lead to osteoarthritis and it is claimed to be a potential way of action for candidate drugs. Downstream effects depend on the receptors ALK1/ALK5 ratio, which changes with ageing and in OA</p><p>Transforming growth factor, beta (e.g. Tgfb1): MGI:98725, NCBI gene: 21803</p><p>By binding to different receptors of the activin-receptor like kinase (ALK) family, TGFβ induces intracellular carboxy-terminal (C-terminal) phosphorylation of receptor-regulated Smad (R-Smad) proteins. The type of activated receptor will define which R-smad are activated knowing that in cartilage, phosphorylated Smad2/3 and Smad1/5 have opposing functions regarding stable chondrocytes maintenance</p><p>TGF-β superfamily members act through a heteromeric receptor complex, comprised of type I and type II receptors (TβRI &amp; TβRII) at the cell surface that transduce intracellular signals via Smad3, Smad complex or the non-canonical-Smad-independent signaling pathway (that is, p38 mitogen-activated protein kinase/p38 MAPK)</p><p>Mice expressing a dominant negative TβRII exhibit articular cartilage degeneration similar to that observed in human OA. Abnormal expression of type X collagen is found in the articular cartilage of these mice</p><p>Active TGFβ is a 25 kD dimer that signals via heteromeric complexes of transmembrane serine/threonine type I and type II receptors, most commonly tetramers composed of two type I and two type II receptors. The type I receptors, also termed activin receptor-like kinases (ALKs), act downstream of type II receptors and determine receptor specificity. The canonical signalling route of TGFβ is via the broadly expressed type I receptor ALK5, but in chondrocytes and other cell types additional ALKs, such as ALK1, can be involved</p></body>
        </notes>
        <annotation>
	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/">
	<rdf:Description rdf:about="#b6ce15ee-69e7-4196-a75f-8cc7e7f0222d">
	<dcterms:modified rdf:parseType="Resource">
	<dcterms:W3CDTF>2021-02-16T17:16:58Z</dcterms:W3CDTF>
	</dcterms:modified>
	</rdf:Description>
	</rdf:RDF>
	</annotation>
            </qual:qualitativeSpecies>
    </qual:listOfQualitativeSpecies>
    <qual:listOfTransitions xmlns:qual="http://www.sbml.org/sbml/level3/version1/qual/version1">
      <qual:transition qual:id="tr_S_1">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>MAPK pathways are involved in FOXOs downregulation in a JNK dependant way. No information was found about the downstream transcription factor involved in that regulation so the inhibitory effect was attributed to a joint effect  (mutliplicative term) of the two effectors of JNK in the model: ELK1 and ATF2.</p><p>interleukin-1β or tumour necrosis factor also caused rapid downregulation of FoxO1 via c-Jun N-terminal kinase (JNK) of which Elk1 and ATF2 are downstream effectors in the model</p><p>IL-1β and TNF-α supress FOXO1 expression in chondrocytes. This effect is reflected by an inhibitory link between NFkB, the downstream transcriptional effector, and FOXO in the GRN</p><p>TGF-b contributes to FOXO1 transcriptonal expression: the downstream effector of TGF-b in the model is ATF2</p></body>
        </notes>
        <qual:listOfInputs>
          <qual:input qual:id="tr_S_1_in_S_55" qual:qualitativeSpecies="S_55" qual:sign="negative" qual:thresholdLevel="1" qual:transitionEffect="none"/>
          <qual:input qual:id="tr_S_1_in_S_48" qual:qualitativeSpecies="S_48" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none"/>
          <qual:input qual:id="tr_S_1_in_S_52" qual:qualitativeSpecies="S_52" qual:sign="negative" qual:thresholdLevel="1" qual:transitionEffect="none"/>
          <qual:input qual:id="tr_S_1_in_S_32" qual:qualitativeSpecies="S_32" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none"/>
        </qual:listOfInputs>
        <qual:listOfOutputs>
          <qual:output qual:qualitativeSpecies="S_1" qual:transitionEffect="assignmentLevel"/>
        </qual:listOfOutputs>
        <qual:listOfFunctionTerms>
          <qual:defaultTerm qual:resultLevel="0">
          </qual:defaultTerm>
          <qual:functionTerm qual:resultLevel="1">
            <math xmlns="http://www.w3.org/1998/Math/MathML">            
              <apply>
                <eq/>
                <ci> S_48 </ci>
                <cn type="integer"> 1 </cn>
              </apply>
            </math>
                    </qual:functionTerm>
        </qual:listOfFunctionTerms>
      </qual:transition>
      <qual:transition qual:id="tr_S_2">
        <qual:listOfInputs>
          <qual:input qual:id="tr_S_2_in_S_25" qual:qualitativeSpecies="S_25" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>BMP signalling induces Dlx5 gene expression, Smad Complex is the downstream effector of BMP pathway in the model.</p><p>BMP2 induction of Runx2 expression passes is mediated by Dlx5 upregulation. Overexpression of Smad1 or Smad5  stimulate Dlx5 transcription</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_2_in_S_27" qual:qualitativeSpecies="S_27" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>MEF2C is required for normal Dlx5 expression (reference for cranofacial developement)</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_2_in_S_48" qual:qualitativeSpecies="S_48" qual:sign="negative" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>TGF-B1 signalling suppresses Dlx5 expression, it is modeled by inhibtion of Dlx5 expression by Smad3, the downtream transcription fator of TGF-B1 pathway</p></body>
            </notes>
          </qual:input>
        </qual:listOfInputs>
        <qual:listOfOutputs>
          <qual:output qual:qualitativeSpecies="S_2" qual:transitionEffect="assignmentLevel"/>
        </qual:listOfOutputs>
        <qual:listOfFunctionTerms>
          <qual:defaultTerm qual:resultLevel="0">
          </qual:defaultTerm>
          <qual:functionTerm qual:resultLevel="1">
            <math xmlns="http://www.w3.org/1998/Math/MathML">            
              <apply>
                <or/>
                <apply>
                  <eq/>
                  <ci> S_25 </ci>
                  <cn type="integer"> 1 </cn>
                </apply>
                <apply>
                  <eq/>
                  <ci> S_27 </ci>
                  <cn type="integer"> 1 </cn>
                </apply>
              </apply>
            </math>
                    </qual:functionTerm>
        </qual:listOfFunctionTerms>
      </qual:transition>
      <qual:transition qual:id="tr_S_4">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>Phosphorylation of SOX9 by cyclic AMP-dependent protein kinase A enhances SOX9 transcriptional activity</p></body>
        </notes>
        <qual:listOfInputs>
          <qual:input qual:id="tr_S_4_in_S_4" qual:qualitativeSpecies="S_4" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Sox9 regulates its own activity in chondrocyte via a positive feedback loop</p><p>Sox9 is involved in an autoregultaory loop wth Nkx3.2. Sox9 can maintain its own expression</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_4_in_S_23" qual:qualitativeSpecies="S_23" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>p38 is the transcription factor at the origin of BMP2-induced Sox9 expression. BMP-2/p38 rather than BMP-2/Smad pathway is responsible for modulating the function of Sox9 during chondrogenesis</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_4_in_S_55" qual:qualitativeSpecies="S_55" qual:sign="negative" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Sox9 is a target of NfkB as a binding site of NfkB was found in Sox9 promotor region. Two different sites</p><p>NFkB could both stimulate and suppress Sox9 activity depending on other unknown factors</p><p>Reference for upregulation</p><p>Reference for repression</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_4_in_S_50" qual:qualitativeSpecies="S_50" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Nkx3.2 and Sox9 could induce each other expression, thereby forming a positive regulatory loop. It would somehow depends on BMP presence.(Reference 'Zeng L. is not really context specific since relative to chondrogenisis in the somites)</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_4_in_S_35" qual:qualitativeSpecies="S_35" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>PKA is a protein kinase and CREB is a prototypical PKA downstream transcription factor transducing PKA signalling in the nucleus.  Its nuclear action is directly operated by PKA in the model.</p><p>CREB (activated by PKA) binds to Sox9 promoter and upregulates its expression</p></body>
            </notes>
          </qual:input>
        </qual:listOfInputs>
        <qual:listOfOutputs>
          <qual:output qual:qualitativeSpecies="S_4" qual:transitionEffect="assignmentLevel"/>
        </qual:listOfOutputs>
        <qual:listOfFunctionTerms>
          <qual:defaultTerm qual:resultLevel="0">
          </qual:defaultTerm>
          <qual:functionTerm qual:resultLevel="1">
            <math xmlns="http://www.w3.org/1998/Math/MathML">            
              <apply>
                <or/>
                <apply>
                  <or/>
                  <apply>
                    <or/>
                    <apply>
                      <eq/>
                      <ci> S_50 </ci>
                      <cn type="integer"> 1 </cn>
                    </apply>
                    <apply>
                      <eq/>
                      <ci> S_23 </ci>
                      <cn type="integer"> 1 </cn>
                    </apply>
                  </apply>
                  <apply>
                    <eq/>
                    <ci> S_4 </ci>
                    <cn type="integer"> 1 </cn>
                  </apply>
                </apply>
                <apply>
                  <eq/>
                  <ci> S_35 </ci>
                  <cn type="integer"> 1 </cn>
                </apply>
              </apply>
            </math>
                    </qual:functionTerm>
        </qual:listOfFunctionTerms>
      </qual:transition>
      <qual:transition qual:id="tr_S_5">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>Various signaling pathways involving the  receptor of inflammation/TAK1/Nfkb axis or the MAPK/p38, JNK and ERK1/2 axis; converge on the MMP13 gene transcription in chondrocyte</p><p>MMPs mRNA increases upon treatment with Il-1beta in articular chondrocytes</p></body>
        </notes>
        <qual:listOfInputs>
          <qual:input qual:id="tr_S_5_in_S_25" qual:qualitativeSpecies="S_25" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none"/>
          <qual:input qual:id="tr_S_5_in_S_53" qual:qualitativeSpecies="S_53" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>See ATF2</p><p>JNK pathway, which mediates phosphorylation of AP-1/Jun family members, as well as Elk-1 and ATF-2, is required for cytokine induction of MMP-1 and MMP-13</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_5_in_S_23" qual:qualitativeSpecies="S_23" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>MAPK/p38 would promote MMP13 expression during osteoarthritis</p><p>Various potential OA treatment  decreasing MMP13 production and expression would pass by inhibtion of MAPK/p38 pathway</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_5_in_S_55" qual:qualitativeSpecies="S_55" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>activation of NfKB pathway promotes production of catabolic enzymes such as MMP13 during OA in human articular cartilage.</p><p>Bloackage of MAPK/NfkB pathway in OA chondrocyte reduce MMP13 expression</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_5_in_S_44" qual:qualitativeSpecies="S_44" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>There is a Cbfa1 (Runx2) binding site in MMP13 promoter</p><p>MMP13 is a target gene of Runx2. Runx2 promote MMP13 expression</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_5_in_S_48" qual:qualitativeSpecies="S_48" qual:sign="negative" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>TGF-beta dependant activation of ALK5 trigger anti-anabolic and pro-catabolic signals including reduction of MMP13 expression. The pro-catabolic effect of TGF-beta is tranduced by Smad3 in the model (see ref TGF-B &amp; ALK5).</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_5_in_S_1" qual:qualitativeSpecies="S_1" qual:sign="negative" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Deletion of FOXO resulted in increase Mmp13 expression in articular cartilage</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_5_in_S_9" qual:qualitativeSpecies="S_9" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Hedgehog signalling promotes chondrocyte hypertrophy and upregulation of MMP-13 in human osteoarthritic cartilage</p><p>However there are controversial effet reported since Studies in other cell type show that Gli2 activity downregulate MMP13. (initial growth plate model included a negative link between Gli2 and MMP13)</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_5_in_S_52" qual:qualitativeSpecies="S_52" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>In articular cartilage, FGF1 activates MAPK/ERK1/2 as well as PKC pathways and they coordinately activate Ets1/Elk1 transcription factor. In this way, Ets1 mediate FGF1-induced upregulation of Runx2 and catabolic proteins such as MMP13 and ADAMTS5 (Aggrecanase). In the model the end node 'MMP13' can as well represent Aggrecanase expression since they would be upregulated in similar circumstances</p><p>Elk-1 is a direct target of NFkappaB and induces MMP-13 expression upon activation of the NFkappaB signaling pathway</p><p>MAPKs signal through Ets1 (Elk-1) and promotes expression of MMP13 in OA</p><p>JNK pathway, which mediates phosphorylation of AP-1/Jun family members, as well as Elk-1 and ATF-2, is required for cytokine induction of MMP-1 and MMP-13</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_5_in_S_14" qual:qualitativeSpecies="S_14" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>MMP13 is a downtream target of Hif2-Alpha. Hif2a promotes mmp13 gene expression</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_5_in_S_32" qual:qualitativeSpecies="S_32" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>The Ras-ERK and JNK pathway induces phosphorylation of ATF2 and transcription of downstream targets. MMP13 mRNA expression is activated collaboratively by the MAPK pathways (JNK-ATF2/ERK-Elk1)</p><p>JNK pathway, which mediates phosphorylation of AP-1/Jun family members, as well as Elk-1 and ATF-2, is required for cytokine induction of MMP-1 and MMP-13</p></body>
            </notes>
          </qual:input>
        </qual:listOfInputs>
        <qual:listOfOutputs>
          <qual:output qual:qualitativeSpecies="S_5" qual:transitionEffect="assignmentLevel"/>
        </qual:listOfOutputs>
        <qual:listOfFunctionTerms>
          <qual:defaultTerm qual:resultLevel="0">
          </qual:defaultTerm>
          <qual:functionTerm qual:resultLevel="1">
            <math xmlns="http://www.w3.org/1998/Math/MathML">            
              <apply>
                <or/>
                <apply>
                  <or/>
                  <apply>
                    <or/>
                    <apply>
                      <or/>
                      <apply>
                        <or/>
                        <apply>
                          <or/>
                          <apply>
                            <or/>
                            <apply>
                              <and/>
                              <apply>
                                <eq/>
                                <ci> S_23 </ci>
                                <cn type="integer"> 1 </cn>
                              </apply>
                              <apply>
                                <or/>
                                <apply>
                                  <eq/>
                                  <ci> S_14 </ci>
                                  <cn type="integer"> 1 </cn>
                                </apply>
                                <apply>
                                  <eq/>
                                  <ci> S_44 </ci>
                                  <cn type="integer"> 1 </cn>
                                </apply>
                              </apply>
                            </apply>
                            <apply>
                              <and/>
                              <apply>
                                <eq/>
                                <ci> S_32 </ci>
                                <cn type="integer"> 1 </cn>
                              </apply>
                              <apply>
                                <or/>
                                <apply>
                                  <eq/>
                                  <ci> S_53 </ci>
                                  <cn type="integer"> 1 </cn>
                                </apply>
                                <apply>
                                  <eq/>
                                  <ci> S_52 </ci>
                                  <cn type="integer"> 1 </cn>
                                </apply>
                              </apply>
                            </apply>
                          </apply>
                          <apply>
                            <eq/>
                            <ci> S_52 </ci>
                            <cn type="integer"> 1 </cn>
                          </apply>
                        </apply>
                        <apply>
                          <eq/>
                          <ci> S_55 </ci>
                          <cn type="integer"> 1 </cn>
                        </apply>
                      </apply>
                      <apply>
                        <eq/>
                        <ci> S_44 </ci>
                        <cn type="integer"> 1 </cn>
                      </apply>
                    </apply>
                    <apply>
                      <eq/>
                      <ci> S_9 </ci>
                      <cn type="integer"> 1 </cn>
                    </apply>
                  </apply>
                  <apply>
                    <eq/>
                    <ci> S_14 </ci>
                    <cn type="integer"> 1 </cn>
                  </apply>
                </apply>
                <apply>
                  <eq/>
                  <ci> S_25 </ci>
                  <cn type="integer"> 1 </cn>
                </apply>
              </apply>
            </math>
                    </qual:functionTerm>
        </qual:listOfFunctionTerms>
      </qual:transition>
      <qual:transition qual:id="tr_S_6">
        <qual:listOfInputs>
          <qual:input qual:id="tr_S_6_in_S_11" qual:qualitativeSpecies="S_11" qual:sign="negative" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>There is a Wnt signalling feeback loop, Wnt signalling decreases transcriptional expression of Wnt antagonists Frzb and DKK1 and of BMP antagonist, Grem1</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_6_in_S_4" qual:qualitativeSpecies="S_4" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Grem1 transcript is dowregulated upon depletion of Sox9</p><p>Grem1 transcript level negatively correlate with OA. Grem1 is expressed in non hypetrophic chondrocyte (expressing Sox9). This regulatory link enable Sox9+ chondrocyte to express Grem1 in the model</p></body>
            </notes>
          </qual:input>
        </qual:listOfInputs>
        <qual:listOfOutputs>
          <qual:output qual:qualitativeSpecies="S_6" qual:transitionEffect="assignmentLevel"/>
        </qual:listOfOutputs>
        <qual:listOfFunctionTerms>
          <qual:defaultTerm qual:resultLevel="0">
          </qual:defaultTerm>
          <qual:functionTerm qual:resultLevel="1">
            <math xmlns="http://www.w3.org/1998/Math/MathML">            
              <apply>
                <and/>
                <apply>
                  <eq/>
                  <ci> S_4 </ci>
                  <cn type="integer"> 1 </cn>
                </apply>
                <apply>
                  <not/>
                  <apply>
                    <eq/>
                    <ci> S_11 </ci>
                    <cn type="integer"> 1 </cn>
                  </apply>
                </apply>
              </apply>
            </math>
                    </qual:functionTerm>
        </qual:listOfFunctionTerms>
      </qual:transition>
      <qual:transition qual:id="tr_S_7">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>DKK and FRZB are antognist of Wnt</p></body>
        </notes>
        <qual:listOfInputs>
          <qual:input qual:id="tr_S_7_in_S_9" qual:qualitativeSpecies="S_9" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Hh signalling would promote hypertrophy in a n PthrP-independant pathway. This effect would pass by upregulation of Wnt ligands expression (including Wnt3a) and thus activation of Wnt/b-catenin pathway and downstream targets.</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_7_in_S_45" qual:qualitativeSpecies="S_45" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Msx2 would upregulate wnt promoter</p></body>
            </notes>
          </qual:input>
        </qual:listOfInputs>
        <qual:listOfOutputs>
          <qual:output qual:qualitativeSpecies="S_7" qual:transitionEffect="assignmentLevel"/>
        </qual:listOfOutputs>
        <qual:listOfFunctionTerms>
          <qual:defaultTerm qual:resultLevel="0">
          </qual:defaultTerm>
          <qual:functionTerm qual:resultLevel="1">
            <math xmlns="http://www.w3.org/1998/Math/MathML">            
              <apply>
                <or/>
                <apply>
                  <eq/>
                  <ci> S_9 </ci>
                  <cn type="integer"> 1 </cn>
                </apply>
                <apply>
                  <eq/>
                  <ci> S_45 </ci>
                  <cn type="integer"> 1 </cn>
                </apply>
              </apply>
            </math>
                    </qual:functionTerm>
        </qual:listOfFunctionTerms>
      </qual:transition>
      <qual:transition qual:id="tr_S_8">
        <qual:listOfInputs>
          <qual:input qual:id="tr_S_8_in_S_4" qual:qualitativeSpecies="S_4" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Fgfr1 is upregulated in (pre)hypertorphic chondrocytes, Fgfr3 is expressed in proliferative chondrocyte and disappears in later stage of chondrocyte maturation. To translate this in the model, fgfr1 expression is activated by Runx2 while Fgfr3 by Sox9</p><p>SOX9 upregulates Fgfr3</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_8_in_S_52" qual:qualitativeSpecies="S_52" qual:sign="negative" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>"FGFR3 was negatively regulated by FGF-2 at the transcriptional level through the FGFR1-ERK (extracellular signal-regulated kinase) signaling pathway in human articular chondrocytes." This corroborate with the notion that the balance between fgfr1 and fgfr3 is of high importance for cartilage homeostasis. Elk-1 tranduces ERK1/2 signal into the nucleus, a ERK1/2 dependent inhibition of Fgfr3 was introduce to account for that.</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_8_in_S_31" qual:qualitativeSpecies="S_31" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none"/>
        </qual:listOfInputs>
        <qual:listOfOutputs>
          <qual:output qual:qualitativeSpecies="S_8" qual:transitionEffect="assignmentLevel"/>
        </qual:listOfOutputs>
        <qual:listOfFunctionTerms>
          <qual:defaultTerm qual:resultLevel="0">
          </qual:defaultTerm>
          <qual:functionTerm qual:resultLevel="1">
            <math xmlns="http://www.w3.org/1998/Math/MathML">            
              <apply>
                <eq/>
                <ci> S_4 </ci>
                <cn type="integer"> 1 </cn>
              </apply>
            </math>
                    </qual:functionTerm>
        </qual:listOfFunctionTerms>
      </qual:transition>
      <qual:transition qual:id="tr_S_9">
        <qual:listOfInputs>
          <qual:input qual:id="tr_S_9_in_S_8" qual:qualitativeSpecies="S_8" qual:sign="negative" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Enhanced Indian hedgehog signaling and RUNX2 expression in Fgfr3 conditional KO mice. enhanced Runx2 might be a consequence on Ihh/Gli2 signalling activation</p><p>The mechanisms of action for the regulation of IHH expression by FGFR3 is yet elusive but it would activate ERK/MAPK without donwstream activation of Runx2 or Elk-1 (Ets1) activity but leading to downregulation of Gli2 and Ihh expresion. Even though FGFR3 is not a transcription factor, this effect was modelled by a direct inlfuence of FGFR3 activity on Ihh and GLi2 expression.</p></body>
            </notes>
          </qual:input>
        </qual:listOfInputs>
        <qual:listOfOutputs>
          <qual:output qual:qualitativeSpecies="S_9" qual:transitionEffect="assignmentLevel"/>
        </qual:listOfOutputs>
        <qual:listOfFunctionTerms>
          <qual:defaultTerm qual:resultLevel="0">
          </qual:defaultTerm>
          <qual:functionTerm qual:resultLevel="1">
            <math xmlns="http://www.w3.org/1998/Math/MathML">            
              <apply>
                <not/>
                <apply>
                  <eq/>
                  <ci> S_8 </ci>
                  <cn type="integer"> 1 </cn>
                </apply>
              </apply>
            </math>
                    </qual:functionTerm>
        </qual:listOfFunctionTerms>
      </qual:transition>
      <qual:transition qual:id="tr_S_10">
        <qual:listOfInputs>
          <qual:input qual:id="tr_S_10_in_S_25" qual:qualitativeSpecies="S_25" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>" Stronger BMP signaling results in the upregulation of WNT antagonists, establishing a negative feedback mitigating WNT signaling"</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_10_in_S_11" qual:qualitativeSpecies="S_11" qual:sign="negative" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>There is a Wnt signalling feeback loop, Wnt signalling decreases transcriptional expression of Wnt antagonists Frzb and DKK1 and of BMP antagonist, Grem1</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_10_in_S_4" qual:qualitativeSpecies="S_4" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>FrzB transcript level negatively correlates with OA. FRzB is expressed in non hypetrophic chondrocyte (expressing Sox9). This regulatory link enable Sox9+ chondrocyte to express Frzb in the model</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_10_in_S_55" qual:qualitativeSpecies="S_55" qual:sign="negative" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Single and repeated treatments with Il-1B reduced mRNA levels of FRZB in adult articular chondrocytes. Nfkb being the main transcriptional tranducer of the IL-1b pro inflammatory cytokines, this hypothetic regulatory link between Nfkb and FRZB was added in the model</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_10_in_S_32" qual:qualitativeSpecies="S_32" qual:sign="negative" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Frzb promoter is regulated by direct binding of CREB.</p></body>
            </notes>
          </qual:input>
        </qual:listOfInputs>
        <qual:listOfOutputs>
          <qual:output qual:qualitativeSpecies="S_10" qual:transitionEffect="assignmentLevel"/>
        </qual:listOfOutputs>
        <qual:listOfFunctionTerms>
          <qual:defaultTerm qual:resultLevel="0">
          </qual:defaultTerm>
          <qual:functionTerm qual:resultLevel="1">
            <math xmlns="http://www.w3.org/1998/Math/MathML">            
              <apply>
                <or/>
                <apply>
                  <and/>
                  <apply>
                    <eq/>
                    <ci> S_25 </ci>
                    <cn type="integer"> 1 </cn>
                  </apply>
                  <apply>
                    <not/>
                    <apply>
                      <eq/>
                      <ci> S_11 </ci>
                      <cn type="integer"> 1 </cn>
                    </apply>
                  </apply>
                </apply>
                <apply>
                  <and/>
                  <apply>
                    <eq/>
                    <ci> S_4 </ci>
                    <cn type="integer"> 1 </cn>
                  </apply>
                  <apply>
                    <not/>
                    <apply>
                      <eq/>
                      <ci> S_11 </ci>
                      <cn type="integer"> 1 </cn>
                    </apply>
                  </apply>
                </apply>
              </apply>
            </math>
                    </qual:functionTerm>
        </qual:listOfFunctionTerms>
      </qual:transition>
      <qual:transition qual:id="tr_S_12">
        <qual:listOfInputs>
          <qual:input qual:id="tr_S_12_in_S_11" qual:qualitativeSpecies="S_11" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Mathematically inferred interaction based on microarray data</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_12_in_S_46" qual:qualitativeSpecies="S_46" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Collagen-X expression is increased by BMP signalling (transduced via R-smad here)</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_12_in_S_27" qual:qualitativeSpecies="S_27" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>MEF2C activity is required for normal Col-X promotor activity</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_12_in_S_44" qual:qualitativeSpecies="S_44" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Runx2 induces Collagen10 expression in chondrocyte and contributes to its hypertrophic chondrocyte-specific expression</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_12_in_S_35" qual:qualitativeSpecies="S_35" qual:sign="negative" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>There is a PTH/PTHrP-responsive region in the human COL10A1 enhancer</p><p>PTHrP signalling transduces to the nucleus via PKA/CREB. In the model it is modelled via a direct link between PKA and the target genes, even though PKA is not a transcription factor per say.</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_12_in_S_14" qual:qualitativeSpecies="S_14" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Collagen10 is a downtream target of Hif2-alpha. Hif2a promotes Col-X gene expression.</p></body>
            </notes>
          </qual:input>
        </qual:listOfInputs>
        <qual:listOfOutputs>
          <qual:output qual:qualitativeSpecies="S_12" qual:transitionEffect="assignmentLevel"/>
        </qual:listOfOutputs>
        <qual:listOfFunctionTerms>
          <qual:defaultTerm qual:resultLevel="0">
          </qual:defaultTerm>
          <qual:functionTerm qual:resultLevel="1">
            <math xmlns="http://www.w3.org/1998/Math/MathML">            
              <apply>
                <or/>
                <apply>
                  <or/>
                  <apply>
                    <or/>
                    <apply>
                      <or/>
                      <apply>
                        <and/>
                        <apply>
                          <eq/>
                          <ci> S_11 </ci>
                          <cn type="integer"> 1 </cn>
                        </apply>
                        <apply>
                          <not/>
                          <apply>
                            <eq/>
                            <ci> S_35 </ci>
                            <cn type="integer"> 1 </cn>
                          </apply>
                        </apply>
                      </apply>
                      <apply>
                        <eq/>
                        <ci> S_14 </ci>
                        <cn type="integer"> 1 </cn>
                      </apply>
                    </apply>
                    <apply>
                      <eq/>
                      <ci> S_46 </ci>
                      <cn type="integer"> 1 </cn>
                    </apply>
                  </apply>
                  <apply>
                    <eq/>
                    <ci> S_27 </ci>
                    <cn type="integer"> 1 </cn>
                  </apply>
                </apply>
                <apply>
                  <eq/>
                  <ci> S_44 </ci>
                  <cn type="integer"> 1 </cn>
                </apply>
              </apply>
            </math>
                    </qual:functionTerm>
        </qual:listOfFunctionTerms>
      </qual:transition>
      <qual:transition qual:id="tr_S_13">
        <qual:listOfInputs>
          <qual:input qual:id="tr_S_13_in_S_4" qual:qualitativeSpecies="S_4" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none"/>
          <qual:input qual:id="tr_S_13_in_S_55" qual:qualitativeSpecies="S_55" qual:sign="negative" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>IL-1β has been shown to downregulate TGFβ type II receptor expression and inhibit TGFβ1-induced gene expression and SMAD2–SMAD3 phosphorylation. In the model type II receptors are not represented. The node ALK5 represents the effective heterodimer of type II receptors and the ALK5  type I receptor</p><p>NfKB is the downstream transcriptional effector of pro-inflammatory cytokines and it was elsewhere shown to mediate IL-1B induced modulation of TGFB pathway (through up-regulation of Smad7)</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_13_in_S_48" qual:qualitativeSpecies="S_48" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none"/>
        </qual:listOfInputs>
        <qual:listOfOutputs>
          <qual:output qual:qualitativeSpecies="S_13" qual:transitionEffect="assignmentLevel"/>
        </qual:listOfOutputs>
        <qual:listOfFunctionTerms>
          <qual:defaultTerm qual:resultLevel="0">
          </qual:defaultTerm>
          <qual:functionTerm qual:resultLevel="1">
            <math xmlns="http://www.w3.org/1998/Math/MathML">            
              <apply>
                <or/>
                <apply>
                  <eq/>
                  <ci> S_48 </ci>
                  <cn type="integer"> 1 </cn>
                </apply>
                <apply>
                  <and/>
                  <apply>
                    <eq/>
                    <ci> S_4 </ci>
                    <cn type="integer"> 1 </cn>
                  </apply>
                  <apply>
                    <not/>
                    <apply>
                      <eq/>
                      <ci> S_55 </ci>
                      <cn type="integer"> 1 </cn>
                    </apply>
                  </apply>
                </apply>
              </apply>
            </math>
                    </qual:functionTerm>
        </qual:listOfFunctionTerms>
      </qual:transition>
      <qual:transition qual:id="tr_S_14">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>Induction of HIF2α by Nfkb induces the activation of the Ihh and Runx2.axis followed by various pro-catabolic responses.</p></body>
        </notes>
        <qual:listOfInputs>
          <qual:input qual:id="tr_S_14_in_S_55" qual:qualitativeSpecies="S_55" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>NfkB is an inducer of Hif2-a promoter in chondrocytes, Nfkb would bind to the EPAS1 enhancer promoter upstream of Ihh</p><p>" the proinflammatory cytokines tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β), putative inducers of the NF-κB signal28, increased EPAS1 expression in cultured chondrogenic cells"</p></body>
            </notes>
          </qual:input>
        </qual:listOfInputs>
        <qual:listOfOutputs>
          <qual:output qual:qualitativeSpecies="S_14" qual:transitionEffect="assignmentLevel"/>
        </qual:listOfOutputs>
        <qual:listOfFunctionTerms>
          <qual:defaultTerm qual:resultLevel="0">
          </qual:defaultTerm>
          <qual:functionTerm qual:resultLevel="1">
            <math xmlns="http://www.w3.org/1998/Math/MathML">            
              <apply>
                <eq/>
                <ci> S_55 </ci>
                <cn type="integer"> 1 </cn>
              </apply>
            </math>
                    </qual:functionTerm>
        </qual:listOfFunctionTerms>
      </qual:transition>
      <qual:transition qual:id="tr_S_15">
        <qual:listOfInputs>
          <qual:input qual:id="tr_S_15_in_S_35" qual:qualitativeSpecies="S_35" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Significant and time-dependent upregulations of the expression of cyclin D1 mRNA and CDK4 protein were observed by the treatment with PTHrP, which prevents chondrocyte hypertrophy. PTHrP signalling transduces to the nucleus via PKA/CREB. In the model it is modelled via a direct link between PKA and the target genes (CCND1 in that case)</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_15_in_S_48" qual:qualitativeSpecies="S_48" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Together with ATF2, Smad3 actiavte TGF-beta regulated genes, including CCND1</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_15_in_S_1" qual:qualitativeSpecies="S_1" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>FOXO, in synergy with the TGF-beta pathway (here represented by Smad3) promotes the expression of p21 and cyclin dependant kinase inhibitor.</p><p>FOXO would promote Cyclin D expression (FOXO KEGG pathway)</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_15_in_S_9" qual:qualitativeSpecies="S_9" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>CyclinD1 is a target of Gli2 transcription factors. Gli2 promote CCND1 expression in chondrocyte</p><p>Upregulation of Cyclin D expression by Hh signalling mediates the distinct ability of Hh to promote cellular growth in various systems. (not chondrocyte specific)</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_15_in_S_32" qual:qualitativeSpecies="S_32" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>TGFb induced ATF2/Creb2 activates Cyclin D1 expression</p></body>
            </notes>
          </qual:input>
        </qual:listOfInputs>
        <qual:listOfOutputs>
          <qual:output qual:qualitativeSpecies="S_15" qual:transitionEffect="assignmentLevel"/>
        </qual:listOfOutputs>
        <qual:listOfFunctionTerms>
          <qual:defaultTerm qual:resultLevel="0">
          </qual:defaultTerm>
          <qual:functionTerm qual:resultLevel="1">
            <math xmlns="http://www.w3.org/1998/Math/MathML">            
              <apply>
                <or/>
                <apply>
                  <or/>
                  <apply>
                    <or/>
                    <apply>
                      <eq/>
                      <ci> S_9 </ci>
                      <cn type="integer"> 1 </cn>
                    </apply>
                    <apply>
                      <and/>
                      <apply>
                        <eq/>
                        <ci> S_1 </ci>
                        <cn type="integer"> 1 </cn>
                      </apply>
                      <apply>
                        <eq/>
                        <ci> S_48 </ci>
                        <cn type="integer"> 1 </cn>
                      </apply>
                    </apply>
                  </apply>
                  <apply>
                    <eq/>
                    <ci> S_32 </ci>
                    <cn type="integer"> 1 </cn>
                  </apply>
                </apply>
                <apply>
                  <eq/>
                  <ci> S_35 </ci>
                  <cn type="integer"> 1 </cn>
                </apply>
              </apply>
            </math>
                    </qual:functionTerm>
        </qual:listOfFunctionTerms>
      </qual:transition>
      <qual:transition qual:id="tr_S_16">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>Inhibition of Akt is caused by an increase in protein phosphatase 2A (PP2A)-mediated dephosphorylation (reference not chondrocyte specific)</p><p>Pi3K activates Akt by phosphorylation in chondrocytes. This constitute the analbolic PI3K/Akt pathway</p></body>
        </notes>
        <qual:listOfInputs>
          <qual:input qual:id="tr_S_16_in_S_44" qual:qualitativeSpecies="S_44" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>decrease in Runx2 activity could be the reason for decrease in the level of Akt protein during treatment  of chondrocytic cells with Dexamethasone. Not direct evidence but it Runx2  also known to upregulate Pi3k a direct AKT collaborating protein</p></body>
            </notes>
          </qual:input>
        </qual:listOfInputs>
        <qual:listOfOutputs>
          <qual:output qual:qualitativeSpecies="S_16" qual:transitionEffect="assignmentLevel"/>
        </qual:listOfOutputs>
        <qual:listOfFunctionTerms>
          <qual:defaultTerm qual:resultLevel="0">
          </qual:defaultTerm>
          <qual:functionTerm qual:resultLevel="1">
            <math xmlns="http://www.w3.org/1998/Math/MathML">            
              <apply>
                <eq/>
                <ci> S_44 </ci>
                <cn type="integer"> 1 </cn>
              </apply>
            </math>
                    </qual:functionTerm>
        </qual:listOfFunctionTerms>
      </qual:transition>
      <qual:transition qual:id="tr_S_17">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>Nfkb and IkBa are invovled in a negative regulatory feedback loop since Nfkb is able to promote the expression of its own inhibitor.</p></body>
        </notes>
        <qual:listOfInputs>
          <qual:input qual:id="tr_S_17_in_S_55" qual:qualitativeSpecies="S_55" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none"/>
        </qual:listOfInputs>
        <qual:listOfOutputs>
          <qual:output qual:qualitativeSpecies="S_17" qual:transitionEffect="assignmentLevel"/>
        </qual:listOfOutputs>
        <qual:listOfFunctionTerms>
          <qual:defaultTerm qual:resultLevel="0">
          </qual:defaultTerm>
          <qual:functionTerm qual:resultLevel="1">
            <math xmlns="http://www.w3.org/1998/Math/MathML">            
              <apply>
                <eq/>
                <ci> S_55 </ci>
                <cn type="integer"> 1 </cn>
              </apply>
            </math>
                    </qual:functionTerm>
        </qual:listOfFunctionTerms>
      </qual:transition>
      <qual:transition qual:id="tr_S_19">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>PThrP signall through binding to its transmembranar receptor PPR. In the protein signalling model PTHrP activates PPR.</p></body>
        </notes>
        <qual:listOfInputs>
          <qual:input qual:id="tr_S_19_in_S_25" qual:qualitativeSpecies="S_25" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>BMP2 downtsream effector is Smad complex in the model. "BMP‐2 induced the response of C2C12 cells to PTHrP", this effect passes by upregulation of PTH1R (PPR)</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_19_in_S_4" qual:qualitativeSpecies="S_4" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Sox9 is required for the Ihh - Pthrp/PthrPreceptor loop to prevent conversion of proliferating chondrocytes into hypertrophic chondrocytes. PPR is expressed in prehypertrophic chodrocytes expressing Sox9 so upregulation of PPR expression by Sox9 transcription factor account for that in the model.</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_19_in_S_9" qual:qualitativeSpecies="S_9" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Not direct evidence but Gli2 promotes PTHrP expression in the context of Ihh/PTHrP feedback loop. To mimick activation of PThrP signalling by Ihh signalling, Gli2 also upregulated expression of PThrP receptors (PPR) in the model</p><p>PTHrP receptor PPR would also be a target of Ihh signalling (transduced by GLi2 transcription factor in the model)</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_19_in_S_42" qual:qualitativeSpecies="S_42" qual:sign="negative" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>FGF signalling controls chondrocyte proliferation through the downstream effector STAT1</p><p>FGF/FGFR3 signalling decreases proliferation which is translated by an inhibitory effect of PTHrP receptor (PPR) expression.</p><p>"FGFR3 down-regulates PTH/PTHrP receptor gene expression by mediating JAK/STAT signaling in chondrocytic cell line"</p></body>
            </notes>
          </qual:input>
        </qual:listOfInputs>
        <qual:listOfOutputs>
          <qual:output qual:qualitativeSpecies="S_19" qual:transitionEffect="assignmentLevel"/>
        </qual:listOfOutputs>
        <qual:listOfFunctionTerms>
          <qual:defaultTerm qual:resultLevel="0">
          </qual:defaultTerm>
          <qual:functionTerm qual:resultLevel="1">
            <math xmlns="http://www.w3.org/1998/Math/MathML">            
              <apply>
                <or/>
                <apply>
                  <or/>
                  <apply>
                    <eq/>
                    <ci> S_4 </ci>
                    <cn type="integer"> 1 </cn>
                  </apply>
                  <apply>
                    <eq/>
                    <ci> S_9 </ci>
                    <cn type="integer"> 1 </cn>
                  </apply>
                </apply>
                <apply>
                  <eq/>
                  <ci> S_25 </ci>
                  <cn type="integer"> 1 </cn>
                </apply>
              </apply>
            </math>
                    </qual:functionTerm>
        </qual:listOfFunctionTerms>
      </qual:transition>
      <qual:transition qual:id="tr_S_21">
        <qual:listOfInputs>
          <qual:input qual:id="tr_S_21_in_S_11" qual:qualitativeSpecies="S_11" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>[The Wnt homepage: Nusse website]. There is a positive feedback loop. Activation of Wnt pathway leads to upregulation of Lef/TCF7 gene expression, themselves downstream effectors of Wnt pathway</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_21_in_S_44" qual:qualitativeSpecies="S_44" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>RUNX2 induces Tcf7 (and probably lef1) expression by direct binding to the promoters in chondrocytes</p></body>
            </notes>
          </qual:input>
        </qual:listOfInputs>
        <qual:listOfOutputs>
          <qual:output qual:qualitativeSpecies="S_21" qual:transitionEffect="assignmentLevel"/>
        </qual:listOfOutputs>
        <qual:listOfFunctionTerms>
          <qual:defaultTerm qual:resultLevel="0">
          </qual:defaultTerm>
          <qual:functionTerm qual:resultLevel="1">
            <math xmlns="http://www.w3.org/1998/Math/MathML">            
              <apply>
                <or/>
                <apply>
                  <eq/>
                  <ci> S_44 </ci>
                  <cn type="integer"> 1 </cn>
                </apply>
                <apply>
                  <eq/>
                  <ci> S_11 </ci>
                  <cn type="integer"> 1 </cn>
                </apply>
              </apply>
            </math>
                    </qual:functionTerm>
        </qual:listOfFunctionTerms>
      </qual:transition>
      <qual:transition qual:id="tr_S_22">
        <qual:listOfInputs>
          <qual:input qual:id="tr_S_22_in_S_55" qual:qualitativeSpecies="S_55" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>NF-kappaB subunits (p50 and p65) bind to the NF-kappaB response elements of the BMP-2 gene and increase BMP-2 expression</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_22_in_S_9" qual:qualitativeSpecies="S_9" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Hh signalling would promote BMP gene expression. For instance, Ihh leads to a reduction of BMP2/4</p></body>
            </notes>
          </qual:input>
        </qual:listOfInputs>
        <qual:listOfOutputs>
          <qual:output qual:qualitativeSpecies="S_22" qual:transitionEffect="assignmentLevel"/>
        </qual:listOfOutputs>
        <qual:listOfFunctionTerms>
          <qual:defaultTerm qual:resultLevel="0">
          </qual:defaultTerm>
          <qual:functionTerm qual:resultLevel="1">
            <math xmlns="http://www.w3.org/1998/Math/MathML">            
              <apply>
                <or/>
                <apply>
                  <eq/>
                  <ci> S_9 </ci>
                  <cn type="integer"> 1 </cn>
                </apply>
                <apply>
                  <eq/>
                  <ci> S_55 </ci>
                  <cn type="integer"> 1 </cn>
                </apply>
              </apply>
            </math>
                    </qual:functionTerm>
        </qual:listOfFunctionTerms>
      </qual:transition>
      <qual:transition qual:id="tr_S_23">
        <qual:listOfInputs>
          <qual:input qual:id="tr_S_23_in_S_36" qual:qualitativeSpecies="S_36" qual:sign="negative" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Mathematically inferred interaction based on microarray data</p></body>
            </notes>
          </qual:input>
        </qual:listOfInputs>
        <qual:listOfOutputs>
          <qual:output qual:qualitativeSpecies="S_23" qual:transitionEffect="assignmentLevel"/>
        </qual:listOfOutputs>
        <qual:listOfFunctionTerms>
          <qual:defaultTerm qual:resultLevel="0">
          </qual:defaultTerm>
          <qual:functionTerm qual:resultLevel="1">
            <math xmlns="http://www.w3.org/1998/Math/MathML">            
              <apply>
                <not/>
                <apply>
                  <eq/>
                  <ci> S_36 </ci>
                  <cn type="integer"> 1 </cn>
                </apply>
              </apply>
            </math>
                    </qual:functionTerm>
        </qual:listOfFunctionTerms>
      </qual:transition>
      <qual:transition qual:id="tr_S_24">
        <qual:listOfInputs>
          <qual:input qual:id="tr_S_24_in_S_55" qual:qualitativeSpecies="S_55" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>NfkB was proven to bind to IGF-1R promotor. It stimulates its expression</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_24_in_S_48" qual:qualitativeSpecies="S_48" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>TGF-beta and IGFI were shown to have a combined effect on chondrocyte differentiation. Moreover, TGFbeta treatment would increase the number of IGFI receptor in articular chondrocyte. TGFbeta is not a transcription factor so the aforementionned observation are taken into account by upregulation of IGFI-R expression by TGF-beta's downstream effector: Smad3</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_24_in_S_42" qual:qualitativeSpecies="S_42" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none"/>
        </qual:listOfInputs>
        <qual:listOfOutputs>
          <qual:output qual:qualitativeSpecies="S_24" qual:transitionEffect="assignmentLevel"/>
        </qual:listOfOutputs>
        <qual:listOfFunctionTerms>
          <qual:defaultTerm qual:resultLevel="0">
          </qual:defaultTerm>
          <qual:functionTerm qual:resultLevel="1">
            <math xmlns="http://www.w3.org/1998/Math/MathML">            
              <apply>
                <or/>
                <apply>
                  <or/>
                  <apply>
                    <eq/>
                    <ci> S_55 </ci>
                    <cn type="integer"> 1 </cn>
                  </apply>
                  <apply>
                    <eq/>
                    <ci> S_48 </ci>
                    <cn type="integer"> 1 </cn>
                  </apply>
                </apply>
                <apply>
                  <eq/>
                  <ci> S_42 </ci>
                  <cn type="integer"> 1 </cn>
                </apply>
              </apply>
            </math>
                    </qual:functionTerm>
        </qual:listOfFunctionTerms>
      </qual:transition>
      <qual:transition qual:id="tr_S_26">
        <qual:listOfInputs>
          <qual:input qual:id="tr_S_26_in_S_53" qual:qualitativeSpecies="S_53" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Effect of ATF2 in the model is sytsematically implemented in conjonction with JNK signalling pathway (multipicative term). Indeed,  ATF2 is a downstream effector mediatiung JNK sigbaling pathway. Moroever trnascriptional binding domain of c-JUN confirmed by Gene Card database (GH12J052180, https://www.genecards.org/cgi-bin/carddisp.pl?gene=ACVRL1&amp;keywords=ALK1)</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_26_in_S_21" qual:qualitativeSpecies="S_21" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Lef1 binding site was found in the ALK1 promoter (GeneCard https://www.genecards.org/cgi-bin/carddisp.pl?gene=ACVRL1&amp;keywords=ALK1)</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_26_in_S_44" qual:qualitativeSpecies="S_44" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Alk1 are overexpressed in hypertrophic chondrocytes and OA/ Runx2 being a master controller of the hypertrophic programme, a positive regulatory interaction was hypothesized. The existence of binding domains for the RUNX familly of transcription factors in the ALK1 promoter region was suported by GeneCard database (https://www.genecards.org/cgi-bin/carddisp.pl?gene=ACVRL1&amp;keywords=ALK1 )</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_26_in_S_48" qual:qualitativeSpecies="S_48" qual:sign="negative" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Binding of active TGFβ to activin receptor-like kinase 5 (ALK5) stimulates the expression of latent TGFβ1 and ALK5 while downregulating the expression of ALK1.</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_26_in_S_32" qual:qualitativeSpecies="S_32" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Mathematically inferred interaction based on microarray data and presence of promoter binding domain for ATF2/c-JUN on ALK1 supported by Gene Card database (https://www.genecards.org/cgi-bin/carddisp.pl?gene=ACVRL1&amp;keywords=ALK1)</p></body>
            </notes>
          </qual:input>
        </qual:listOfInputs>
        <qual:listOfOutputs>
          <qual:output qual:qualitativeSpecies="S_26" qual:transitionEffect="assignmentLevel"/>
        </qual:listOfOutputs>
        <qual:listOfFunctionTerms>
          <qual:defaultTerm qual:resultLevel="0">
          </qual:defaultTerm>
          <qual:functionTerm qual:resultLevel="1">
            <math xmlns="http://www.w3.org/1998/Math/MathML">            
              <apply>
                <or/>
                <apply>
                  <or/>
                  <apply>
                    <and/>
                    <apply>
                      <and/>
                      <apply>
                        <eq/>
                        <ci> S_32 </ci>
                        <cn type="integer"> 1 </cn>
                      </apply>
                      <apply>
                        <eq/>
                        <ci> S_53 </ci>
                        <cn type="integer"> 1 </cn>
                      </apply>
                    </apply>
                    <apply>
                      <not/>
                      <apply>
                        <eq/>
                        <ci> S_48 </ci>
                        <cn type="integer"> 1 </cn>
                      </apply>
                    </apply>
                  </apply>
                  <apply>
                    <and/>
                    <apply>
                      <eq/>
                      <ci> S_44 </ci>
                      <cn type="integer"> 1 </cn>
                    </apply>
                    <apply>
                      <not/>
                      <apply>
                        <eq/>
                        <ci> S_48 </ci>
                        <cn type="integer"> 1 </cn>
                      </apply>
                    </apply>
                  </apply>
                </apply>
                <apply>
                  <eq/>
                  <ci> S_21 </ci>
                  <cn type="integer"> 1 </cn>
                </apply>
              </apply>
            </math>
                    </qual:functionTerm>
        </qual:listOfFunctionTerms>
      </qual:transition>
      <qual:transition qual:id="tr_S_27">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>PTHrP induces dephosphorylation of histone deacetylase 4 (HDAC4), which promotes nuclear translocation of HDAC4 and repression of MEF2 transcriptional activity.</p><p>HDAC4 has a repressive effect on MEF2C-dependant expression of Runx2</p></body>
        </notes>
        <qual:listOfInputs>
          <qual:input qual:id="tr_S_27_in_S_44" qual:qualitativeSpecies="S_44" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>MEF2C might be a target of Runx2 since it is differentially expressed in Runx2-double KO mouse model</p></body>
            </notes>
          </qual:input>
        </qual:listOfInputs>
        <qual:listOfOutputs>
          <qual:output qual:qualitativeSpecies="S_27" qual:transitionEffect="assignmentLevel"/>
        </qual:listOfOutputs>
        <qual:listOfFunctionTerms>
          <qual:defaultTerm qual:resultLevel="0">
          </qual:defaultTerm>
          <qual:functionTerm qual:resultLevel="1">
            <math xmlns="http://www.w3.org/1998/Math/MathML">            
              <apply>
                <eq/>
                <ci> S_44 </ci>
                <cn type="integer"> 1 </cn>
              </apply>
            </math>
                    </qual:functionTerm>
        </qual:listOfFunctionTerms>
      </qual:transition>
      <qual:transition qual:id="tr_S_28">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>up regulation of gene expression level</p></body>
        </notes>
        <qual:listOfInputs>
          <qual:input qual:id="tr_S_28_in_S_25" qual:qualitativeSpecies="S_25" qual:sign="negative" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>BMP signalling inhibits FGF signalling by inhibiting Fgfr1 expression in growth plate chondrocytes</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_28_in_S_44" qual:qualitativeSpecies="S_44" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Fgfr1 is upregulated in (pre)hypertorphic chondrocytes, Fgfr3 is expressed in proliferative chondrocyte and disappears in later stage of chodrocyte maturation. Fgfr1 was reported to be upregulated in OA chondrocyte. To translate this in the model, fgfr1 expression is activated by Runx2 a major regulator gene activator in hypertophy</p></body>
            </notes>
          </qual:input>
        </qual:listOfInputs>
        <qual:listOfOutputs>
          <qual:output qual:qualitativeSpecies="S_28" qual:transitionEffect="assignmentLevel"/>
        </qual:listOfOutputs>
        <qual:listOfFunctionTerms>
          <qual:defaultTerm qual:resultLevel="0">
          </qual:defaultTerm>
          <qual:functionTerm qual:resultLevel="1">
            <math xmlns="http://www.w3.org/1998/Math/MathML">            
              <apply>
                <eq/>
                <ci> S_44 </ci>
                <cn type="integer"> 1 </cn>
              </apply>
            </math>
                    </qual:functionTerm>
        </qual:listOfFunctionTerms>
      </qual:transition>
      <qual:transition qual:id="tr_S_29">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>Pro-inflammatory cytokines (e.g. IL-1β and TNF-α) activate signals that lead to the inhibition of Col2a1 expression</p></body>
        </notes>
        <qual:listOfInputs>
          <qual:input qual:id="tr_S_29_in_S_11" qual:qualitativeSpecies="S_11" qual:sign="negative" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Mathematically inferred interaction based on microarray data</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_29_in_S_4" qual:qualitativeSpecies="S_4" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Sox9 promotes expression of Collagen-II in chondrocyte, a major ECM protein whose presence is important for healthy articular cartilage maintenance</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_29_in_S_21" qual:qualitativeSpecies="S_21" qual:sign="negative" qual:thresholdLevel="1" qual:transitionEffect="none"/>
          <qual:input qual:id="tr_S_29_in_S_50" qual:qualitativeSpecies="S_50" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Nkx3.2 promote chondrogenisis notably by inducing Col-II expression and GAG</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_29_in_S_1" qual:qualitativeSpecies="S_1" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Inflammatory signals reduce Col2a1 expression, notably by blocking FOXO activty</p></body>
            </notes>
          </qual:input>
        </qual:listOfInputs>
        <qual:listOfOutputs>
          <qual:output qual:qualitativeSpecies="S_29" qual:transitionEffect="assignmentLevel"/>
        </qual:listOfOutputs>
        <qual:listOfFunctionTerms>
          <qual:defaultTerm qual:resultLevel="0">
          </qual:defaultTerm>
          <qual:functionTerm qual:resultLevel="1">
            <math xmlns="http://www.w3.org/1998/Math/MathML">            
              <apply>
                <or/>
                <apply>
                  <or/>
                  <apply>
                    <eq/>
                    <ci> S_50 </ci>
                    <cn type="integer"> 1 </cn>
                  </apply>
                  <apply>
                    <eq/>
                    <ci> S_4 </ci>
                    <cn type="integer"> 1 </cn>
                  </apply>
                </apply>
                <apply>
                  <eq/>
                  <ci> S_1 </ci>
                  <cn type="integer"> 1 </cn>
                </apply>
              </apply>
            </math>
                    </qual:functionTerm>
        </qual:listOfFunctionTerms>
      </qual:transition>
      <qual:transition qual:id="tr_S_30">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>Upon treatment with pro-inflammatory cytokines, in particular with IL-1B, proteoglycans and GAG are not only degraded but an overall decrease of the biosynthesis is also observed in cartilage. Nfkb being the main transcriptional effector of IL-1B in the model and the production rate of proteoglycan being dependant on the gene expression, we introduce this regulatory link between Nfkb and the node for proteoglycans in the GRN</p></body>
        </notes>
        <qual:listOfInputs>
          <qual:input qual:id="tr_S_30_in_S_4" qual:qualitativeSpecies="S_4" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Overexpression of Sox9 increase Acan mRNA expression, suggesting that SOX9 regulates proteoglycan production as it does for other ECM proteins such as type II collagen.</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_30_in_S_55" qual:qualitativeSpecies="S_55" qual:sign="negative" qual:thresholdLevel="1" qual:transitionEffect="none"/>
          <qual:input qual:id="tr_S_30_in_S_1" qual:qualitativeSpecies="S_1" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>FOXO regulate expression of Prg4 (Proteolycan 4) in articular cartilage</p></body>
            </notes>
          </qual:input>
        </qual:listOfInputs>
        <qual:listOfOutputs>
          <qual:output qual:qualitativeSpecies="S_30" qual:transitionEffect="assignmentLevel"/>
        </qual:listOfOutputs>
        <qual:listOfFunctionTerms>
          <qual:defaultTerm qual:resultLevel="0">
          </qual:defaultTerm>
          <qual:functionTerm qual:resultLevel="1">
            <math xmlns="http://www.w3.org/1998/Math/MathML">            
              <apply>
                <or/>
                <apply>
                  <and/>
                  <apply>
                    <eq/>
                    <ci> S_4 </ci>
                    <cn type="integer"> 1 </cn>
                  </apply>
                  <apply>
                    <not/>
                    <apply>
                      <eq/>
                      <ci> S_55 </ci>
                      <cn type="integer"> 1 </cn>
                    </apply>
                  </apply>
                </apply>
                <apply>
                  <and/>
                  <apply>
                    <eq/>
                    <ci> S_1 </ci>
                    <cn type="integer"> 1 </cn>
                  </apply>
                  <apply>
                    <not/>
                    <apply>
                      <eq/>
                      <ci> S_55 </ci>
                      <cn type="integer"> 1 </cn>
                    </apply>
                  </apply>
                </apply>
              </apply>
            </math>
                    </qual:functionTerm>
        </qual:listOfFunctionTerms>
      </qual:transition>
      <qual:transition qual:id="tr_S_31">
        <qual:listOfInputs>
          <qual:input qual:id="tr_S_31_in_S_27" qual:qualitativeSpecies="S_27" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Mathematically inferred interaction based on microarray data</p></body>
            </notes>
          </qual:input>
        </qual:listOfInputs>
        <qual:listOfOutputs>
          <qual:output qual:qualitativeSpecies="S_31" qual:transitionEffect="assignmentLevel"/>
        </qual:listOfOutputs>
        <qual:listOfFunctionTerms>
          <qual:defaultTerm qual:resultLevel="0">
          </qual:defaultTerm>
          <qual:functionTerm qual:resultLevel="1">
            <math xmlns="http://www.w3.org/1998/Math/MathML">            
              <apply>
                <eq/>
                <ci> S_27 </ci>
                <cn type="integer"> 1 </cn>
              </apply>
            </math>
                    </qual:functionTerm>
        </qual:listOfFunctionTerms>
      </qual:transition>
      <qual:transition qual:id="tr_S_33">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>Promoter activation by Runx2 and B-catenin leading to FGF ligands gene expression. Migh need further refinement to distinguish between the different types of FGF ligands (FGF2, FGF18, etc..)</p></body>
        </notes>
        <qual:listOfInputs>
          <qual:input qual:id="tr_S_33_in_S_11" qual:qualitativeSpecies="S_11" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Wnt signalling is requited to induces FGF (at least FGF-8, FGF-10) in mouse growth plate</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_33_in_S_44" qual:qualitativeSpecies="S_44" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>RUNX2 controls FGF18 expression in the perichondrium and thus FGFR3 activation and chondrocyte proliferation in the growth plate. Does Runx2 also promotes fgf18 in (AC) chodnrocyte</p></body>
            </notes>
          </qual:input>
        </qual:listOfInputs>
        <qual:listOfOutputs>
          <qual:output qual:qualitativeSpecies="S_33" qual:transitionEffect="assignmentLevel"/>
        </qual:listOfOutputs>
        <qual:listOfFunctionTerms>
          <qual:defaultTerm qual:resultLevel="0">
          </qual:defaultTerm>
          <qual:functionTerm qual:resultLevel="1">
            <math xmlns="http://www.w3.org/1998/Math/MathML">            
              <apply>
                <or/>
                <apply>
                  <eq/>
                  <ci> S_44 </ci>
                  <cn type="integer"> 1 </cn>
                </apply>
                <apply>
                  <eq/>
                  <ci> S_11 </ci>
                  <cn type="integer"> 1 </cn>
                </apply>
              </apply>
            </math>
                    </qual:functionTerm>
        </qual:listOfFunctionTerms>
      </qual:transition>
      <qual:transition qual:id="tr_S_34">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>the Wnt pathway control hypertophic differentiation by antagonizing PTHrP signaling via Beta-catenin. However, PTHrP is not upregulated by the Wnt pathway, Beta-catenin would rather block the PTHrP pathway activity by targetting downstream effectors.. An important downstream effector for that pathway in our model is the PP2A protein. Therefore we included an inhibitory transcriptional interaction between beta-catenin and PP2A</p><p>PP2A is the direct messenger of PKA since PKA activates it by phosphorylation. When activated, PP2A subesquently modulates other downtream molecules</p></body>
        </notes>
        <qual:listOfInputs>
          <qual:input qual:id="tr_S_34_in_S_11" qual:qualitativeSpecies="S_11" qual:sign="negative" qual:thresholdLevel="1" qual:transitionEffect="none"/>
        </qual:listOfInputs>
        <qual:listOfOutputs>
          <qual:output qual:qualitativeSpecies="S_34" qual:transitionEffect="assignmentLevel"/>
        </qual:listOfOutputs>
        <qual:listOfFunctionTerms>
          <qual:defaultTerm qual:resultLevel="0">
          </qual:defaultTerm>
          <qual:functionTerm qual:resultLevel="1">
            <math xmlns="http://www.w3.org/1998/Math/MathML">            
              <apply>
                <not/>
                <apply>
                  <eq/>
                  <ci> S_11 </ci>
                  <cn type="integer"> 1 </cn>
                </apply>
              </apply>
            </math>
                    </qual:functionTerm>
        </qual:listOfFunctionTerms>
      </qual:transition>
      <qual:transition qual:id="tr_S_36">
        <qual:listOfInputs>
          <qual:input qual:id="tr_S_36_in_S_25" qual:qualitativeSpecies="S_25" qual:sign="negative" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Decrease of delta-EF1 expression by BMP siganlling (but not shown in chondrocyte: breast cancer)</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_36_in_S_46" qual:qualitativeSpecies="S_46" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Mathematically inferred interaction based on microarray data</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_36_in_S_55" qual:qualitativeSpecies="S_55" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>p65 (NfkB fragment) increased ZEB-1 promoter activity. And Zeb1 is induced by TNF-a (an inducer of NfkB). (Reference not chondrocyte-specific but if binding site of NfkB present in Zeb1--promoter, it is likely to be also present in chondrocyte were Nfkb also happend to be expressed))</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_36_in_S_48" qual:qualitativeSpecies="S_48" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>TGF-beta would induce the expression of Ets1, which in turn activates deltaEF1 promoter activity. (not chondrocyte specific reference). This is summarized by activation of d-EF1 expression by Smad3, which is a downstream nuclear effector of TGFbeta</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_36_in_S_52" qual:qualitativeSpecies="S_52" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none"/>
        </qual:listOfInputs>
        <qual:listOfOutputs>
          <qual:output qual:qualitativeSpecies="S_36" qual:transitionEffect="assignmentLevel"/>
        </qual:listOfOutputs>
        <qual:listOfFunctionTerms>
          <qual:defaultTerm qual:resultLevel="0">
          </qual:defaultTerm>
          <qual:functionTerm qual:resultLevel="1">
            <math xmlns="http://www.w3.org/1998/Math/MathML">            
              <apply>
                <or/>
                <apply>
                  <or/>
                  <apply>
                    <or/>
                    <apply>
                      <and/>
                      <apply>
                        <eq/>
                        <ci> S_48 </ci>
                        <cn type="integer"> 1 </cn>
                      </apply>
                      <apply>
                        <not/>
                        <apply>
                          <eq/>
                          <ci> S_25 </ci>
                          <cn type="integer"> 1 </cn>
                        </apply>
                      </apply>
                    </apply>
                    <apply>
                      <eq/>
                      <ci> S_55 </ci>
                      <cn type="integer"> 1 </cn>
                    </apply>
                  </apply>
                  <apply>
                    <eq/>
                    <ci> S_52 </ci>
                    <cn type="integer"> 1 </cn>
                  </apply>
                </apply>
                <apply>
                  <and/>
                  <apply>
                    <eq/>
                    <ci> S_46 </ci>
                    <cn type="integer"> 1 </cn>
                  </apply>
                  <apply>
                    <not/>
                    <apply>
                      <eq/>
                      <ci> S_25 </ci>
                      <cn type="integer"> 1 </cn>
                    </apply>
                  </apply>
                </apply>
              </apply>
            </math>
                    </qual:functionTerm>
        </qual:listOfFunctionTerms>
      </qual:transition>
      <qual:transition qual:id="tr_S_40">
        <qual:listOfInputs>
          <qual:input qual:id="tr_S_40_in_S_55" qual:qualitativeSpecies="S_55" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>NfKb binds and activates IGFI promotor</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_40_in_S_35" qual:qualitativeSpecies="S_35" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Uncertainty</p></body>
            </notes>
          </qual:input>
        </qual:listOfInputs>
        <qual:listOfOutputs>
          <qual:output qual:qualitativeSpecies="S_40" qual:transitionEffect="assignmentLevel"/>
        </qual:listOfOutputs>
        <qual:listOfFunctionTerms>
          <qual:defaultTerm qual:resultLevel="0">
          </qual:defaultTerm>
          <qual:functionTerm qual:resultLevel="1">
            <math xmlns="http://www.w3.org/1998/Math/MathML">            
              <apply>
                <or/>
                <apply>
                  <eq/>
                  <ci> S_35 </ci>
                  <cn type="integer"> 1 </cn>
                </apply>
                <apply>
                  <eq/>
                  <ci> S_55 </ci>
                  <cn type="integer"> 1 </cn>
                </apply>
              </apply>
            </math>
                    </qual:functionTerm>
        </qual:listOfFunctionTerms>
      </qual:transition>
      <qual:transition qual:id="tr_S_41">
        <qual:listOfInputs>
          <qual:input qual:id="tr_S_41_in_S_25" qual:qualitativeSpecies="S_25" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>BMP signalling induces Ihh expression (but effect of BMP on proliferation in independant of Ihh). BMP signalling is tranduces by Smad complex in the model</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_41_in_S_55" qual:qualitativeSpecies="S_55" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>(weak link:not chondrocyte context + no ihh but shh)  Nuclear factor-kappaB regulates hedghog signalling in part through upregulation of shh expression.</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_41_in_S_44" qual:qualitativeSpecies="S_44" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Runx2 activates Ihh promoter and thus stimulates its expression</p><p>mutant mice deficient for Runx2 leads to a decrease in Ihh expression</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_41_in_S_36" qual:qualitativeSpecies="S_36" qual:sign="negative" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>delta-EF1 (or Zeb1) is a negative regulator of Ihh expression in growth plate chondrocytes</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_41_in_S_38" qual:qualitativeSpecies="S_38" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>ATF4 influences chondrocyte proliferation by activating Ihh expression</p><p>ATF4-deficient mice show reduced expression of Ihh, ATF4 binds to the promoter region of the Ihh gene, and treatment with a hedgehog agonist rescue limb development in ATF4-deficient mice</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_41_in_S_8" qual:qualitativeSpecies="S_8" qual:sign="negative" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Ihh expression is up-regulated in absence or with deletion of FGFR3 in articular chondrocytes. FGFR3 is not a transcriptional regulator so this link is most likely indirect but the mechanism is not yet fully understood, so we accounted for that information with the current indirect link</p><p>The mechanisms of action for the regulation of IHH expression by FGFR3 is still elusive but it go through activation of the ERK/MAPK axis without donwstream activation of Runx2 or Elk-1 (Ets1) activity but leading to downregulation of Gli2 and Ihh expresion. Even though FGFR3 is not a transcription factor, this effect was modelled by a direct inlfuence of FGFR3 activity on Ihh and GLi2 expression.</p><p>Data of RT-PCR revealed that Gli1, Runx2 , Col10 Mmp13 and Adamts5  expressions were increased significantly in Fgfr3 cKO mice compared to Cre-negative mice. This effect is reduced by treatment with inhibitor of Ihh signalling.</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_41_in_S_41" qual:qualitativeSpecies="S_41" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none"/>
        </qual:listOfInputs>
        <qual:listOfOutputs>
          <qual:output qual:qualitativeSpecies="S_41" qual:transitionEffect="assignmentLevel"/>
        </qual:listOfOutputs>
        <qual:listOfFunctionTerms>
          <qual:defaultTerm qual:resultLevel="0">
          </qual:defaultTerm>
          <qual:functionTerm qual:resultLevel="1">
            <math xmlns="http://www.w3.org/1998/Math/MathML">            
              <apply>
                <or/>
                <apply>
                  <or/>
                  <apply>
                    <or/>
                    <apply>
                      <or/>
                      <apply>
                        <eq/>
                        <ci> S_44 </ci>
                        <cn type="integer"> 1 </cn>
                      </apply>
                      <apply>
                        <eq/>
                        <ci> S_55 </ci>
                        <cn type="integer"> 1 </cn>
                      </apply>
                    </apply>
                    <apply>
                      <and/>
                      <apply>
                        <eq/>
                        <ci> S_41 </ci>
                        <cn type="integer"> 1 </cn>
                      </apply>
                      <apply>
                        <not/>
                        <apply>
                          <or/>
                          <apply>
                            <eq/>
                            <ci> S_8 </ci>
                            <cn type="integer"> 1 </cn>
                          </apply>
                          <apply>
                            <eq/>
                            <ci> S_36 </ci>
                            <cn type="integer"> 1 </cn>
                          </apply>
                        </apply>
                      </apply>
                    </apply>
                  </apply>
                  <apply>
                    <eq/>
                    <ci> S_25 </ci>
                    <cn type="integer"> 1 </cn>
                  </apply>
                </apply>
                <apply>
                  <and/>
                  <apply>
                    <eq/>
                    <ci> S_38 </ci>
                    <cn type="integer"> 1 </cn>
                  </apply>
                  <apply>
                    <not/>
                    <apply>
                      <eq/>
                      <ci> S_36 </ci>
                      <cn type="integer"> 1 </cn>
                    </apply>
                  </apply>
                </apply>
              </apply>
            </math>
                    </qual:functionTerm>
        </qual:listOfFunctionTerms>
      </qual:transition>
      <qual:transition qual:id="tr_S_43">
        <qual:listOfInputs>
          <qual:input qual:id="tr_S_43_in_S_25" qual:qualitativeSpecies="S_25" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Stronger BMP signaling results in the upregulation of WNT antagonists, establishing a negative feedback mitigating WNT signaling</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_43_in_S_11" qual:qualitativeSpecies="S_11" qual:sign="negative" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>There is a Wnt signalling feeback loop, Wnt signalling decreases transcriptional expression of Wnt antagonists Frzb and DKK1 and of BMP antagonist, Grem1</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_43_in_S_4" qual:qualitativeSpecies="S_4" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>DKK1 transcript level negatively correlates with OA. DKK1 is expressed in non hypetrophic chondrocyte (expressing Sox9). This regulatory link enable Sox9+ chondrocyte to express DKK1 in the model. This is a calibration choice but not direct supporting evidence/</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_43_in_S_55" qual:qualitativeSpecies="S_55" qual:sign="negative" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Single and repeated treatments with Il-1B reduced mRNA levels of DKK1 in adult articular chondrocytes. Nfkb being the main transcriptional tranducer of the IL-1b pro inflammatory cytokines, this hypothetic regulatory link between Nfkb and Dkk1was added in the model</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_43_in_S_32" qual:qualitativeSpecies="S_32" qual:sign="negative" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>TGF-b regulate Wnt signalling in chondrocytes by downregulating the Wtn antagonist DKK1, in a p38 dependant way. The downstream nuclear effector of the TGF-b/p38 pathway in the model</p></body>
            </notes>
          </qual:input>
        </qual:listOfInputs>
        <qual:listOfOutputs>
          <qual:output qual:qualitativeSpecies="S_43" qual:transitionEffect="assignmentLevel"/>
        </qual:listOfOutputs>
        <qual:listOfFunctionTerms>
          <qual:defaultTerm qual:resultLevel="0">
          </qual:defaultTerm>
          <qual:functionTerm qual:resultLevel="1">
            <math xmlns="http://www.w3.org/1998/Math/MathML">            
              <apply>
                <or/>
                <apply>
                  <and/>
                  <apply>
                    <eq/>
                    <ci> S_25 </ci>
                    <cn type="integer"> 1 </cn>
                  </apply>
                  <apply>
                    <not/>
                    <apply>
                      <eq/>
                      <ci> S_11 </ci>
                      <cn type="integer"> 1 </cn>
                    </apply>
                  </apply>
                </apply>
                <apply>
                  <and/>
                  <apply>
                    <eq/>
                    <ci> S_4 </ci>
                    <cn type="integer"> 1 </cn>
                  </apply>
                  <apply>
                    <not/>
                    <apply>
                      <eq/>
                      <ci> S_11 </ci>
                      <cn type="integer"> 1 </cn>
                    </apply>
                  </apply>
                </apply>
              </apply>
            </math>
                    </qual:functionTerm>
        </qual:listOfFunctionTerms>
      </qual:transition>
      <qual:transition qual:id="tr_S_44">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>HDAC4 represses Runx2 expression at the gene level. This occurs indirectly by acting as a corepressor of MEF2C transcription factor. This action is modeled by inhibtiion of MEF2C protein activity by HDAC4 at the PPI level</p><p>PTHrP inhibits Runx2 expression through PKA/CREB2 pathway. In the model, this is translated by direct inhibition of Runx2 at the gene expressio</p></body>
        </notes>
        <qual:listOfInputs>
          <qual:input qual:id="tr_S_44_in_S_25" qual:qualitativeSpecies="S_25" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>See Nkx3.2</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_44_in_S_2" qual:qualitativeSpecies="S_2" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Dlx5 induces Runx2 expression by direct binding to its promoter</p><p>BMP-2 induces Runx2 expression via Dlx5 but Runx2-induced expression by TGFB1 does not pass by Dlx5</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_44_in_S_27" qual:qualitativeSpecies="S_27" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>MEF2C directly upreglate Runx2 expression level and thereby control chondrocyte hypertrophy</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_44_in_S_21" qual:qualitativeSpecies="S_21" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>the Wnt-mediated induction of Runx2 expression passes by binding of TCF/Lef on the Runx2 promoter.(At least in chicken chodnrocytes)</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_44_in_S_50" qual:qualitativeSpecies="S_50" qual:sign="negative" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>BMP signalling is required for Nkx3.2 to serve as a transcriptional repressor of chondrogenisis. (NB: stong reference in somitic chondrogenisis, but it is yet to prove in join cartilage maturation, although we can assume that if Nkx3.2 protein and Smad (downstream of BMP) interact in this cell type, they are likely to interact also in join chondrocytes from a docking point of view)</p><p>Nkx3/Bapx1 is a transcriptional repressor selectively expressed by proliferative chondrocytes in growth cartilage. Nkx3/Bapx1 inhibits Runx2 expression</p><p>Nkx3.2 represses Runx2 expression as part of a tight positive regulatory system that includes Sox9</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_44_in_S_44" qual:qualitativeSpecies="S_44" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none"/>
          <qual:input qual:id="tr_S_44_in_S_35" qual:qualitativeSpecies="S_35" qual:sign="negative" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>PthrP inhibits Runx2 expression in chondrocytes via PKA/CREB signalling pathway. CREB is the downstream nulcear effector of PKA but it is directly represented by PKA itself in the model</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_44_in_S_9" qual:qualitativeSpecies="S_9" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Ihh signalling promotes Runx2 expression during chondrocgenisis. Gli1 was shown to mediate this effect but Gli2 is the generic transcription factor node downtream of Ihh pathway in the model.</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_44_in_S_52" qual:qualitativeSpecies="S_52" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>In articular cartilage, FGF1 activates MAPK/ERK1/2 as well as PKC pathways and they coordinately activates Ets1 transcription factor (Ets1 and Elk1 transcription factors downstream of ERK activation are represented by the same node in the model).In this way, Ets1 mediate FGF1-induced upregulation of Runx2 and catabolic proteins such as MMP13 and ADAMTS5 (Aggrecanase). In the model the end node 'MMP13' can as well represent Aggrecanase expression since they would be upregulated in similar circumstances</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_44_in_S_45" qual:qualitativeSpecies="S_45" qual:sign="negative" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>"Dlx5 specifically transactivates the Runx2 P1 promoter, and its action on the P1 promoter is antagonized by Msx2."</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_44_in_S_14" qual:qualitativeSpecies="S_14" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Hif-2a upregulates Runx2 promoter activity</p></body>
            </notes>
          </qual:input>
        </qual:listOfInputs>
        <qual:listOfOutputs>
          <qual:output qual:qualitativeSpecies="S_44" qual:transitionEffect="assignmentLevel"/>
        </qual:listOfOutputs>
        <qual:listOfFunctionTerms>
          <qual:defaultTerm qual:resultLevel="0">
          </qual:defaultTerm>
          <qual:functionTerm qual:resultLevel="1">
            <math xmlns="http://www.w3.org/1998/Math/MathML">            
              <apply>
                <or/>
                <apply>
                  <or/>
                  <apply>
                    <or/>
                    <apply>
                      <or/>
                      <apply>
                        <or/>
                        <apply>
                          <or/>
                          <apply>
                            <and/>
                            <apply>
                              <eq/>
                              <ci> S_44 </ci>
                              <cn type="integer"> 1 </cn>
                            </apply>
                            <apply>
                              <not/>
                              <apply>
                                <or/>
                                <apply>
                                  <or/>
                                  <apply>
                                    <and/>
                                    <apply>
                                      <eq/>
                                      <ci> S_50 </ci>
                                      <cn type="integer"> 1 </cn>
                                    </apply>
                                    <apply>
                                      <eq/>
                                      <ci> S_25 </ci>
                                      <cn type="integer"> 1 </cn>
                                    </apply>
                                  </apply>
                                  <apply>
                                    <eq/>
                                    <ci> S_45 </ci>
                                    <cn type="integer"> 1 </cn>
                                  </apply>
                                </apply>
                                <apply>
                                  <eq/>
                                  <ci> S_35 </ci>
                                  <cn type="integer"> 1 </cn>
                                </apply>
                              </apply>
                            </apply>
                          </apply>
                          <apply>
                            <eq/>
                            <ci> S_2 </ci>
                            <cn type="integer"> 1 </cn>
                          </apply>
                        </apply>
                        <apply>
                          <and/>
                          <apply>
                            <eq/>
                            <ci> S_9 </ci>
                            <cn type="integer"> 1 </cn>
                          </apply>
                          <apply>
                            <not/>
                            <apply>
                              <or/>
                              <apply>
                                <and/>
                                <apply>
                                  <eq/>
                                  <ci> S_50 </ci>
                                  <cn type="integer"> 1 </cn>
                                </apply>
                                <apply>
                                  <eq/>
                                  <ci> S_25 </ci>
                                  <cn type="integer"> 1 </cn>
                                </apply>
                              </apply>
                              <apply>
                                <eq/>
                                <ci> S_45 </ci>
                                <cn type="integer"> 1 </cn>
                              </apply>
                            </apply>
                          </apply>
                        </apply>
                      </apply>
                      <apply>
                        <eq/>
                        <ci> S_27 </ci>
                        <cn type="integer"> 1 </cn>
                      </apply>
                    </apply>
                    <apply>
                      <and/>
                      <apply>
                        <eq/>
                        <ci> S_21 </ci>
                        <cn type="integer"> 1 </cn>
                      </apply>
                      <apply>
                        <not/>
                        <apply>
                          <and/>
                          <apply>
                            <eq/>
                            <ci> S_50 </ci>
                            <cn type="integer"> 1 </cn>
                          </apply>
                          <apply>
                            <eq/>
                            <ci> S_25 </ci>
                            <cn type="integer"> 1 </cn>
                          </apply>
                        </apply>
                      </apply>
                    </apply>
                  </apply>
                  <apply>
                    <and/>
                    <apply>
                      <eq/>
                      <ci> S_52 </ci>
                      <cn type="integer"> 1 </cn>
                    </apply>
                    <apply>
                      <not/>
                      <apply>
                        <or/>
                        <apply>
                          <or/>
                          <apply>
                            <and/>
                            <apply>
                              <eq/>
                              <ci> S_50 </ci>
                              <cn type="integer"> 1 </cn>
                            </apply>
                            <apply>
                              <eq/>
                              <ci> S_25 </ci>
                              <cn type="integer"> 1 </cn>
                            </apply>
                          </apply>
                          <apply>
                            <eq/>
                            <ci> S_45 </ci>
                            <cn type="integer"> 1 </cn>
                          </apply>
                        </apply>
                        <apply>
                          <eq/>
                          <ci> S_35 </ci>
                          <cn type="integer"> 1 </cn>
                        </apply>
                      </apply>
                    </apply>
                  </apply>
                </apply>
                <apply>
                  <eq/>
                  <ci> S_14 </ci>
                  <cn type="integer"> 1 </cn>
                </apply>
              </apply>
            </math>
                    </qual:functionTerm>
        </qual:listOfFunctionTerms>
      </qual:transition>
      <qual:transition qual:id="tr_S_45">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>Dlx5 stimulates Runx2 activity and negatively regulates Msx2 activity. Evidence suggests Dlx5 might achieve these effects through interfering with interactions between Msx2 and Runx2 (Dodig et al., 1999).</p></body>
        </notes>
        <qual:listOfInputs>
          <qual:input qual:id="tr_S_45_in_S_25" qual:qualitativeSpecies="S_25" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>BMP-2 upregulates expression of Msx2 in chondrocytes. "The stimulatory effect of Msx2 on chondrocyte maturation was enhanced by overexpression of Smad1 and Smad4 " Smad1 and Smad4 form the Smad Complex which tranduce BMP signalling in the nucleus</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_45_in_S_2" qual:qualitativeSpecies="S_2" qual:sign="negative" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Dlx5 can bind to Msx2 promotor and was shown to be involved in negative feedback loop. They might influence each other transcriptional level by supression of their respective expression</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_45_in_S_48" qual:qualitativeSpecies="S_48" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>TGF-B1 signalling would stimulate Msx2 expression (weak reference or not chondrocyte specifc)</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_45_in_S_45" qual:qualitativeSpecies="S_45" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Msx2 was shown to bind to its own promoter sequence thereby autoactivating its expression. (in transgenic mouses, during limb development)</p></body>
            </notes>
          </qual:input>
        </qual:listOfInputs>
        <qual:listOfOutputs>
          <qual:output qual:qualitativeSpecies="S_45" qual:transitionEffect="assignmentLevel"/>
        </qual:listOfOutputs>
        <qual:listOfFunctionTerms>
          <qual:defaultTerm qual:resultLevel="0">
          </qual:defaultTerm>
          <qual:functionTerm qual:resultLevel="1">
            <math xmlns="http://www.w3.org/1998/Math/MathML">            
              <apply>
                <or/>
                <apply>
                  <or/>
                  <apply>
                    <eq/>
                    <ci> S_25 </ci>
                    <cn type="integer"> 1 </cn>
                  </apply>
                  <apply>
                    <eq/>
                    <ci> S_45 </ci>
                    <cn type="integer"> 1 </cn>
                  </apply>
                </apply>
                <apply>
                  <eq/>
                  <ci> S_48 </ci>
                  <cn type="integer"> 1 </cn>
                </apply>
              </apply>
            </math>
                    </qual:functionTerm>
        </qual:listOfFunctionTerms>
      </qual:transition>
      <qual:transition qual:id="tr_S_46">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>BMP binds to Type II receptors which activates type I receptors and subsequently activates R-smads by phosphorylation</p></body>
        </notes>
        <qual:listOfInputs>
          <qual:input qual:id="tr_S_46_in_S_36" qual:qualitativeSpecies="S_36" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Mathematically inferred interaction based on microarray data</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_46_in_S_38" qual:qualitativeSpecies="S_38" qual:sign="negative" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Mathematically inferred interaction based on microarray data</p></body>
            </notes>
          </qual:input>
        </qual:listOfInputs>
        <qual:listOfOutputs>
          <qual:output qual:qualitativeSpecies="S_46" qual:transitionEffect="assignmentLevel"/>
        </qual:listOfOutputs>
        <qual:listOfFunctionTerms>
          <qual:defaultTerm qual:resultLevel="0">
          </qual:defaultTerm>
          <qual:functionTerm qual:resultLevel="1">
            <math xmlns="http://www.w3.org/1998/Math/MathML">            
              <apply>
                <and/>
                <apply>
                  <eq/>
                  <ci> S_36 </ci>
                  <cn type="integer"> 1 </cn>
                </apply>
                <apply>
                  <not/>
                  <apply>
                    <eq/>
                    <ci> S_38 </ci>
                    <cn type="integer"> 1 </cn>
                  </apply>
                </apply>
              </apply>
            </math>
                    </qual:functionTerm>
        </qual:listOfFunctionTerms>
      </qual:transition>
      <qual:transition qual:id="tr_S_49">
        <qual:listOfInputs>
          <qual:input qual:id="tr_S_49_in_S_25" qual:qualitativeSpecies="S_25" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>"Induction of Smad6 and Smad7 expression by BMP and TGF-β represents an auto-inhibitory feedback mechanism for ligand-induced signalling"</p><p>SmadComplex is the canonical downstream effector of BMP signalling</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_49_in_S_55" qual:qualitativeSpecies="S_55" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>NfKb induces Smad7 expression, leading to inhibition of TGFB pathway</p><p>In OA chondrocytes, IL-1 upregulates SMAD7 expression (an intracellular TGFβ signalling inhibitor) via NF-κB activation</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_49_in_S_48" qual:qualitativeSpecies="S_48" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>"Induction of Smad6 and Smad7 expression by BMP and TGF-β represents an auto-inhibitory feedback mechanism for ligand-induced signalling"</p><p>Smad3 is the canonical downstream effector of TGFB signalling</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_49_in_S_42" qual:qualitativeSpecies="S_42" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>STAT proteins induces Smad7 expression, leading to inhibition of TGF-β signalling</p></body>
            </notes>
          </qual:input>
        </qual:listOfInputs>
        <qual:listOfOutputs>
          <qual:output qual:qualitativeSpecies="S_49" qual:transitionEffect="assignmentLevel"/>
        </qual:listOfOutputs>
        <qual:listOfFunctionTerms>
          <qual:defaultTerm qual:resultLevel="0">
          </qual:defaultTerm>
          <qual:functionTerm qual:resultLevel="1">
            <math xmlns="http://www.w3.org/1998/Math/MathML">            
              <apply>
                <or/>
                <apply>
                  <or/>
                  <apply>
                    <or/>
                    <apply>
                      <eq/>
                      <ci> S_42 </ci>
                      <cn type="integer"> 1 </cn>
                    </apply>
                    <apply>
                      <eq/>
                      <ci> S_48 </ci>
                      <cn type="integer"> 1 </cn>
                    </apply>
                  </apply>
                  <apply>
                    <eq/>
                    <ci> S_55 </ci>
                    <cn type="integer"> 1 </cn>
                  </apply>
                </apply>
                <apply>
                  <eq/>
                  <ci> S_25 </ci>
                  <cn type="integer"> 1 </cn>
                </apply>
              </apply>
            </math>
                    </qual:functionTerm>
        </qual:listOfFunctionTerms>
      </qual:transition>
      <qual:transition qual:id="tr_S_50">
        <qual:listOfInputs>
          <qual:input qual:id="tr_S_50_in_S_4" qual:qualitativeSpecies="S_4" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Sox9 directly binds to Nkx3.2 promoter and up-regulates its expression. Nkx3.2 expression contributes to Runx2 downregulation by Sox9 activity</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_50_in_S_35" qual:qualitativeSpecies="S_35" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>PTHrP signals block chondrocyte hypertrophy, in part, by maintaining the expression of Nkx3.2/Bapx1. PKA is not a transcription factor therefore this link is indirect, however it allows to account for the upregulation of Nkx3.2 by PthrP signalling</p></body>
            </notes>
          </qual:input>
        </qual:listOfInputs>
        <qual:listOfOutputs>
          <qual:output qual:qualitativeSpecies="S_50" qual:transitionEffect="assignmentLevel"/>
        </qual:listOfOutputs>
        <qual:listOfFunctionTerms>
          <qual:defaultTerm qual:resultLevel="0">
          </qual:defaultTerm>
          <qual:functionTerm qual:resultLevel="1">
            <math xmlns="http://www.w3.org/1998/Math/MathML">            
              <apply>
                <or/>
                <apply>
                  <eq/>
                  <ci> S_35 </ci>
                  <cn type="integer"> 1 </cn>
                </apply>
                <apply>
                  <eq/>
                  <ci> S_4 </ci>
                  <cn type="integer"> 1 </cn>
                </apply>
              </apply>
            </math>
                    </qual:functionTerm>
        </qual:listOfFunctionTerms>
      </qual:transition>
      <qual:transition qual:id="tr_S_51">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>Pro-inflammatory cytokines are involved in a positive feedback loop. These cytokines activate the IRAL/TAK1/ NF-kB axis. Nfkb upregulates the epression of numerous chemokines and pro-inflammatory cytokines. Moreover MAPK pathways, activated by pro-inflmmatory cytokines, promote production of MMP13 and regulate the expression of pro-inflammatory cytokines such as TNFα and IL-1</p><p>MAPK pathways (Ras-ERK-Elk1/ JNK-ATF2) converge to upregulates expression of pro-inflammatory cytokines,such as TNFα and IL-1, during osteoarthritis</p></body>
        </notes>
        <qual:listOfInputs>
          <qual:input qual:id="tr_S_51_in_S_53" qual:qualitativeSpecies="S_53" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none"/>
          <qual:input qual:id="tr_S_51_in_S_55" qual:qualitativeSpecies="S_55" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none"/>
          <qual:input qual:id="tr_S_51_in_S_52" qual:qualitativeSpecies="S_52" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none"/>
          <qual:input qual:id="tr_S_51_in_S_32" qual:qualitativeSpecies="S_32" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none"/>
        </qual:listOfInputs>
        <qual:listOfOutputs>
          <qual:output qual:qualitativeSpecies="S_51" qual:transitionEffect="assignmentLevel"/>
        </qual:listOfOutputs>
        <qual:listOfFunctionTerms>
          <qual:defaultTerm qual:resultLevel="0">
          </qual:defaultTerm>
          <qual:functionTerm qual:resultLevel="1">
            <math xmlns="http://www.w3.org/1998/Math/MathML">            
              <apply>
                <or/>
                <apply>
                  <eq/>
                  <ci> S_55 </ci>
                  <cn type="integer"> 1 </cn>
                </apply>
                <apply>
                  <and/>
                  <apply>
                    <eq/>
                    <ci> S_32 </ci>
                    <cn type="integer"> 1 </cn>
                  </apply>
                  <apply>
                    <or/>
                    <apply>
                      <eq/>
                      <ci> S_53 </ci>
                      <cn type="integer"> 1 </cn>
                    </apply>
                    <apply>
                      <eq/>
                      <ci> S_52 </ci>
                      <cn type="integer"> 1 </cn>
                    </apply>
                  </apply>
                </apply>
              </apply>
            </math>
                    </qual:functionTerm>
        </qual:listOfFunctionTerms>
      </qual:transition>
      <qual:transition qual:id="tr_S_54">
        <qual:listOfInputs>
          <qual:input qual:id="tr_S_54_in_S_1" qual:qualitativeSpecies="S_1" qual:sign="negative" qual:thresholdLevel="1" qual:transitionEffect="none"/>
        </qual:listOfInputs>
        <qual:listOfOutputs>
          <qual:output qual:qualitativeSpecies="S_54" qual:transitionEffect="assignmentLevel"/>
        </qual:listOfOutputs>
        <qual:listOfFunctionTerms>
          <qual:defaultTerm qual:resultLevel="0">
          </qual:defaultTerm>
          <qual:functionTerm qual:resultLevel="1">
            <math xmlns="http://www.w3.org/1998/Math/MathML">            
              <apply>
                <not/>
                <apply>
                  <eq/>
                  <ci> S_1 </ci>
                  <cn type="integer"> 1 </cn>
                </apply>
              </apply>
            </math>
                    </qual:functionTerm>
        </qual:listOfFunctionTerms>
      </qual:transition>
      <qual:transition qual:id="tr_S_56">
        <notes>
          <body xmlns="http://www.w3.org/1999/xhtml">
            <p>Insulin-like growth factors related pathway may lead to the induction of SOCS, which inhibits the JAK/STAT axis in return; as a feedback inhibition.</p></body>
        </notes>
        <qual:listOfInputs>
          <qual:input qual:id="tr_S_56_in_S_24" qual:qualitativeSpecies="S_24" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Insulin-like growth factors related pathway may lead to the induction of SOCS, which inhibits the JAK/STAT axis in return; as a feedback inhibition.</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_56_in_S_8" qual:qualitativeSpecies="S_8" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>FGF2 siganlling in chondrocytes induces expression of CIS, SOCS1 and SOC3 inhibitors of cytokine receptors, which is likely mediated by the FGFR3 related pathway</p></body>
            </notes>
          </qual:input>
        </qual:listOfInputs>
        <qual:listOfOutputs>
          <qual:output qual:qualitativeSpecies="S_56" qual:transitionEffect="assignmentLevel"/>
        </qual:listOfOutputs>
        <qual:listOfFunctionTerms>
          <qual:defaultTerm qual:resultLevel="0">
          </qual:defaultTerm>
          <qual:functionTerm qual:resultLevel="1">
            <math xmlns="http://www.w3.org/1998/Math/MathML">            
              <apply>
                <or/>
                <apply>
                  <eq/>
                  <ci> S_8 </ci>
                  <cn type="integer"> 1 </cn>
                </apply>
                <apply>
                  <eq/>
                  <ci> S_24 </ci>
                  <cn type="integer"> 1 </cn>
                </apply>
              </apply>
            </math>
                    </qual:functionTerm>
        </qual:listOfFunctionTerms>
      </qual:transition>
      <qual:transition qual:id="tr_S_57">
        <qual:listOfInputs>
          <qual:input qual:id="tr_S_57_in_S_4" qual:qualitativeSpecies="S_4" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Sox9 also mediates PrhrP upregulation in collaboration with ihh/Gli2</p><p>SOX9 binds to promotor region of PTHrP and up regulate its expression. Sox9 would inhibits late stage maturation of chondrocyte via up-regulation of parathyroid hormone-related protein.</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_57_in_S_48" qual:qualitativeSpecies="S_48" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>TGF-B controls and promotes PthrP expression through Smad3 signaling</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_57_in_S_9" qual:qualitativeSpecies="S_9" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Ihh and PthrP are involved in a negative feedback loop, which is major in regulating chondrocyte hypetrophy. Ihh induces production of PthrP, in the model Ihh signal is transduced by Gli2 in the nucleus.</p><p>transition from proliferating into hypertrophic chondrocytes is regulated by Gli3-dependent expression of PTHrP. Gli3 is another effector downtsream to Ihh signalling. All downstream effects are summarized by the Gli2 node in the model</p><p>Ihh/Gli2 and Sox9 collaborate to mediate PthrP upregulation during endochondral ossification</p></body>
            </notes>
          </qual:input>
        </qual:listOfInputs>
        <qual:listOfOutputs>
          <qual:output qual:qualitativeSpecies="S_57" qual:transitionEffect="assignmentLevel"/>
        </qual:listOfOutputs>
        <qual:listOfFunctionTerms>
          <qual:defaultTerm qual:resultLevel="0">
          </qual:defaultTerm>
          <qual:functionTerm qual:resultLevel="1">
            <math xmlns="http://www.w3.org/1998/Math/MathML">            
              <apply>
                <or/>
                <apply>
                  <or/>
                  <apply>
                    <eq/>
                    <ci> S_4 </ci>
                    <cn type="integer"> 1 </cn>
                  </apply>
                  <apply>
                    <eq/>
                    <ci> S_48 </ci>
                    <cn type="integer"> 1 </cn>
                  </apply>
                </apply>
                <apply>
                  <and/>
                  <apply>
                    <eq/>
                    <ci> S_9 </ci>
                    <cn type="integer"> 1 </cn>
                  </apply>
                  <apply>
                    <eq/>
                    <ci> S_4 </ci>
                    <cn type="integer"> 1 </cn>
                  </apply>
                </apply>
              </apply>
            </math>
                    </qual:functionTerm>
        </qual:listOfFunctionTerms>
      </qual:transition>
      <qual:transition qual:id="tr_S_59">
        <qual:listOfInputs>
          <qual:input qual:id="tr_S_59_in_S_44" qual:qualitativeSpecies="S_44" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>Runx2 upregulate protein levels of Pi3K by binding to promoter sites upstrem to the Pi3K gene</p></body>
            </notes>
          </qual:input>
        </qual:listOfInputs>
        <qual:listOfOutputs>
          <qual:output qual:qualitativeSpecies="S_59" qual:transitionEffect="assignmentLevel"/>
        </qual:listOfOutputs>
        <qual:listOfFunctionTerms>
          <qual:defaultTerm qual:resultLevel="0">
          </qual:defaultTerm>
          <qual:functionTerm qual:resultLevel="1">
            <math xmlns="http://www.w3.org/1998/Math/MathML">            
              <apply>
                <eq/>
                <ci> S_44 </ci>
                <cn type="integer"> 1 </cn>
              </apply>
            </math>
                    </qual:functionTerm>
        </qual:listOfFunctionTerms>
      </qual:transition>
      <qual:transition qual:id="tr_S_60">
        <qual:listOfInputs>
          <qual:input qual:id="tr_S_60_in_S_48" qual:qualitativeSpecies="S_48" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none"/>
          <qual:input qual:id="tr_S_60_in_S_9" qual:qualitativeSpecies="S_9" qual:sign="positive" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>TGFB signalling would be regulated by Ihh/Gli2  signalling (NB: reference discutable)</p></body>
            </notes>
          </qual:input>
          <qual:input qual:id="tr_S_60_in_S_52" qual:qualitativeSpecies="S_52" qual:sign="negative" qual:thresholdLevel="1" qual:transitionEffect="none">
            <notes>
              <body xmlns="http://www.w3.org/1999/xhtml">
                <p>FGF1 (2) treatment in chondrocyte was shown to increase quantity of TGFbeta protein (directly related to expression level in this model). Ets1 is the transcription factor acting as the effector downstream of FGF/ERK1/2 pathway</p></body>
            </notes>
          </qual:input>
        </qual:listOfInputs>
        <qual:listOfOutputs>
          <qual:output qual:qualitativeSpecies="S_60" qual:transitionEffect="assignmentLevel"/>
        </qual:listOfOutputs>
        <qual:listOfFunctionTerms>
          <qual:defaultTerm qual:resultLevel="0">
          </qual:defaultTerm>
          <qual:functionTerm qual:resultLevel="1">
            <math xmlns="http://www.w3.org/1998/Math/MathML">            
              <apply>
                <or/>
                <apply>
                  <eq/>
                  <ci> S_9 </ci>
                  <cn type="integer"> 1 </cn>
                </apply>
                <apply>
                  <and/>
                  <apply>
                    <eq/>
                    <ci> S_48 </ci>
                    <cn type="integer"> 1 </cn>
                  </apply>
                  <apply>
                    <not/>
                    <apply>
                      <eq/>
                      <ci> S_52 </ci>
                      <cn type="integer"> 1 </cn>
                    </apply>
                  </apply>
                </apply>
              </apply>
            </math>
                    </qual:functionTerm>
        </qual:listOfFunctionTerms>
      </qual:transition>
    </qual:listOfTransitions>
    <listOfCompartments>
      <compartment constant="true" id="cytosol" name="cytosol"/>
    </listOfCompartments>
  </model>
</sbml>